GLP-1 Market
LLY $1166.51 ▼ -1.4% NVO $38.06 ▼ -1.3% PFE $28.37 ▼ -0.1% VKTX $26.65 ▼ -6.0% KLRA $10.77 ▼ -4.9% GPCR $22.31 ▼ -6.7% RHHBY $53.77 ▼ -0.6%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Warfarin Sodium

Company
BrightGene Bio-Medical Technology Co., Ltd.
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
27 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

27 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 14, 2026

Find a Clinical Trial Near Me

See recruiting studies for Warfarin Sodium and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02318342

    Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation

    Not yet reported Cedars-Sinai Medical Center 3000 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Prosthetic Valve Thrombosis
    View official trial listing →
  • Recruiting NCT NCT03032835

    Partners Calciphylaxis Biobank

    Massachusetts General Hospital 300 participants Est. completion 2030-12 1 site
    Chronic kidney disease Other conditions: Calciphylaxis, Calcific Uremic Arteriolopathy, End Stage Renal Disease
    View official trial listing →
  • Recruiting NCT NCT03225820

    Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities

    University of Chicago 1000 participants Est. completion 2028-03 2 sites
    Other conditions: Information Seeking Behavior
    View official trial listing →
  • Recruiting NCT NCT03862859

    The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis

    Not yet reported Nicholas Carlson 718 participants Est. completion 2027-01 13 sites
    Cardiovascular disease Other conditions: Atrial Fibrillation and Flutter, Major Bleed, End-stage Renal Disease
    View official trial listing →
  • Recruiting NCT NCT04258488

    Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement

    Not yet reported Joon Bum Kim 1300 participants Est. completion 2028-12-30 16 sites
    Other conditions: AORTIC VALVE DISEASES, Thromboembolism
    View official trial listing →
  • Recruiting NCT NCT05204212

    Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease

    Not yet reported Prof. Dr. med. Ingo Eitel 430 participants Est. completion 2028-01-14 1 site
    Other conditions: Non-valvular Atrial Fibrillation (NVAF): Paroxysmal, Persistent, Permanent
    View official trial listing →
  • Recruiting NCT NCT05353140

    LAAO Versus NOAC in Patients with AF and PCI

    Not yet reported Xijing Hospital 1386 participants Est. completion 2029-09-20 1 site Stand-alone
    Other conditions: Atrial Fibrillation, Percutaneous Coronary Intervention
    View official trial listing →
  • Recruiting NCT NCT05782270

    Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy

    Not yet reported China National Center for Cardiovascular Diseases 202 participants Est. completion 2026-05-30 1 site Stand-alone
    Other conditions: Anticoagulation, Coronary Endarterectomy
    View official trial listing →
  • Recruiting NCT NCT06075628

    Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry

    Kansas City Heart Rhythm Research Foundation 100 participants Est. completion 2025-12 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Recruiting NCT NCT06401616

    Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)

    Not yet reported Odense University Hospital 1220 participants Est. completion 2028-03 6 sites Stand-alone
    Other conditions: Atrial Fibrillation, Left Atrial Appendage Absent, Anticoagulant Adverse Reaction
    View official trial listing →
  • Recruiting NCT NCT06402851

    Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)

    Not yet reported Hospital Sirio-Libanes 1500 participants Est. completion 2026-12 6 sites Stand-alone
    Chronic kidney disease Other conditions: Atrium; Fibrillation
    View official trial listing →
  • Recruiting NCT NCT06515730

    Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction

    Not yet reported Karolinska Institutet 212 participants Est. completion 2028-07-01 16 sites
    Cardiovascular disease Other conditions: Left Ventricular Thrombus
    View official trial listing →
  • Recruiting NCT NCT06615596

    Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation

    Not yet reported China National Center for Cardiovascular Diseases 3160 participants Est. completion 2029-12-31 12 sites
    Other conditions: Atrial Fibrillation (AF)
    View official trial listing →
  • Recruiting NCT NCT06655376

    Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device

    Not yet reported Columbia University 128 participants Est. completion 2027-04-01 3 sites Stand-alone
    Other conditions: Bleeding, Clot Blood
    View official trial listing →
  • Recruiting NCT NCT06696079

    Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation

    Not yet reported Rahul Raj 332 participants Est. completion 2027-06 6 sites
    Other conditions: Chronic Subdural Hematoma, Atrial Fibrillation (AF)
    View official trial listing →
  • Recruiting NCT NCT06738992

    Safety and Effectiveness of Early Aspirin Administration After Mitral Valve Repair

    Not yet reported Guangdong Provincial People's Hospital 384 participants Est. completion 2027-12-31 1 site
    Other conditions: Mitral Valve Repair Surgery
    View official trial listing →
  • Recruiting NCT NCT06844227

    Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)

    McMaster University 1780 participants Est. completion 2026-12-31 10 sites
    Other conditions: Atrial Fibrillation (AF)
    View official trial listing →
  • Recruiting NCT NCT07349875

    Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial

    Not yet reported Nanjing First Hospital, Nanjing Medical University 3826 participants Est. completion 2030-06-30 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07352358

    Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis

    Not yet reported Xuanwu Hospital, Beijing 72 participants Est. completion 2028-07-01 1 site Stand-alone
    Other conditions: Cerebral Venous Thrombosis
    View official trial listing →
  • Recruiting NCT NCT07441382

    Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

    Not yet reported Guangdong Provincial People's Hospital 200 participants Est. completion 2028-03-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Atrial Fibrillation (AF), Hemorrhage, Frailty, Atrial Appendage, Catheter Ablation, Anticoagulants
    View official trial listing →
  • Recruiting NCT NCT07515664

    Vitamin K for Perioperative Warfarin Management

    Not yet reported University of Michigan 20 participants Est. completion 2026-08 1 site Stand-alone
    Other conditions: Anticoagulant Therapy
    View official trial listing →
  • Recruiting NCT NCT07550816

    Drug-drug Interaction Study of ZT002 Injection in Overweight and Obese Participants

    Not yet reported Beijing QL Biopharmaceutical Co.,Ltd 60 participants Est. completion 2027-03-26 1 site Stand-alone
    Other conditions: Overweight,Obesity
    View official trial listing →
  • Recruiting NCT NCT07658989

    Optimizing Anticoagulation in Pregnancies With Mechanical Heart Valves

    Not yet reported Mount Sinai Hospital, Canada 100 participants Est. completion 2030-12 1 site
    Other conditions: Pregnancy, Prosthetic Heart Valve, Anticoagulant Therapy
    View official trial listing →
  • Recruiting NCT NCT07665723

    An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis

    Not yet reported Hoffmann-La Roche 25 participants Est. completion 2030-12-31 18 sites Stand-alone
    Other conditions: Active Ulcerative Colitis
    View official trial listing →
  • Recruiting NCT NCT07677410

    Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients With Pure Aortic Regurgitation

    Not yet reported Shanghai Zhongshan Hospital 1172 participants Est. completion 2030-07-01 1 site
    Other conditions: Aortic Regurgitation Disease
    View official trial listing →
  • Recruiting NCT NCT07709780

    Apixaban Versus Warfarin for Left Ventricular Thrombus

    Not yet reported University of Arizona 218 participants Est. completion 2029-07-01 1 site
    Other conditions: Left Ventricular Thrombus
    View official trial listing →
  • Recruiting NCT NCT07870941

    A Study on Abnormal Menstrual Bleeding in Chinese Women of Childbearing Age Taking Antithrombotic Drugs After Cardiovascular Surgery

    Shanghai Zhongshan Hospital 1308 participants Est. completion 2027-11-16 1 site
    Cardiovascular disease Other conditions: Uterine Hemorrhage, Antithrombotic Drugs
    View official trial listing →
  • Completed NCT NCT00000463

    Post Coronary Artery Bypass Graft (CABG) Study

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 1998-12
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00000517

    Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)

    Not yet reported Massachusetts General Hospital Est. completion 1991-06
    Cardiovascular disease Other conditions: Arrhythmia, Atrial Fibrillation, Cerebral Embolism and Thrombosis, Cerebrovascular Disorders, Heart Diseases, Thrombophlebitis, Cerebrovascular Accident
    View official trial listing →
  • Completed NCT NCT00000614

    Prevention of Recurrent Venous Thromboembolism (PREVENT)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2004-08
    Cardiovascular disease Other conditions: Heart Diseases, Peripheral Vascular Diseases, Thromboembolism, Vascular Diseases, Venous Thromboembolism
    View official trial listing →
  • Completed NCT NCT00001713

    Treatment for Blood Clots in the Veins of the Legs

    Not yet reported National Institutes of Health Clinical Center (CC) 20 participants Est. completion 2006-01 1 site
    Other conditions: Embolism, Thrombophlebitis
    View official trial listing →
  • Terminated NCT NCT00004728

    Aspirin Or Warfarin To Prevent Stroke

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) Est. completion 2003-07 1 site
    Cardiovascular disease Other conditions: Cerebral Infarction, Atherosclerosis, Constriction, Pathologic
    View official trial listing →
  • Completed NCT NCT00005684

    Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis

    National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2001-01
    Cardiovascular disease Other conditions: Venous Thrombosis, Venous Thromboembolism
    View official trial listing →
  • Completed NCT NCT00024297

    Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters

    Not yet reported Cancer Research Campaign Clinical Trials Centre Est. completion 2009-02 38 sites
    Other conditions: Thromboembolism
    View official trial listing →
  • Completed NCT NCT00041938

    Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

    Not yet reported Columbia University 2305 participants Est. completion 2014-07 64 sites
    Cardiovascular disease Other conditions: Heart Disease, Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00075985

    Following Patients on Warfarin Therapy to See if Differences in Hemorrhagic Complications Exist

    US Department of Veterans Affairs 700 participants Est. completion 2006-04 17 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00097357

    BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

    Not yet reported, Not yet reported Bristol-Myers Squibb 1238 participants Est. completion 2005-12 147 sites
    Other conditions: Venous Thrombosis, Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT00157651

    Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters

    Not yet reported Hamilton Health Sciences Corporation 170 participants Est. completion 2007-03 1 site
    Other conditions: End Stage Renal Disease, Thrombosis, Bleeding
    View official trial listing →
  • Status unknown NCT NCT00162409

    Relationship Between Folic Acid and Warfarin Metabolism and Effect

    Not yet reported Hadassah Medical Organization 400 participants 1 site
    Other conditions: Folic Acid Deficiency
    View official trial listing →
  • Status unknown NCT NCT00162435

    Genetic Determinants of Warfarin Anticoagulation Effect

    Not yet reported Hadassah Medical Organization 500 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Venous Thrombosis, Pulmonary Embolism, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00203580

    Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)

    Not yet reported University of Calgary 910 participants Est. completion 2002-03 1 site
    Other conditions: Thrombosis, Thromboembolism, Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT00203658

    Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin

    Not yet reported University of Calgary 400 participants Est. completion 2000-10 1 site
    Other conditions: Thrombosis, Thromboembolism, Venous Thrombosis
    View official trial listing →
  • Terminated NCT NCT00206063

    Long Term Open Follow-up With H376/95 vs. Warfarin

    Not yet reported AstraZeneca 220 participants Est. completion 2006-04 19 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00235248

    Aortic Arch Related Cerebral Hazard Trial (ARCH)

    Not yet reported Assistance Publique - Hôpitaux de Paris 350 participants Est. completion 2012-07 2 sites
    Other conditions: Brain Infarction, Transient Ischemic Attack, Embolism
    View official trial listing →
  • Completed NCT NCT00244725

    Odiparcil For The Prevention Of Venous Thromboembolism

    Not yet reported GlaxoSmithKline 961 participants Est. completion 2006-09 101 sites
    Other conditions: Deep Vein Thrombosis, Fibrillation, Atrial, Venous Thromboembolism, Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT00245856

    Treatment of Upper Extremity Deep-Vein Thrombosis

    Not yet reported University of Oklahoma 67 participants Est. completion 2011-12 2 sites Stand-alone
    Other conditions: Deep-Vein Thrombosis
    View official trial listing →
  • Completed NCT NCT00287313

    Daily Vitamin K in Patients on Warfarin With Unstable INRs

    Not yet reported University of North Carolina, Chapel Hill 15 participants Est. completion 2006-05 1 site
    Other conditions: Anticoagulants, Warfarin
    View official trial listing →
  • Completed NCT NCT00291525

    Randomized On-X Anticoagulation Trial

    Not yet reported On-X Life Technologies, Inc. 977 participants Est. completion 2023-12-29 49 sites Stand-alone
    Other conditions: Heart Valve Disease
    View official trial listing →
  • Completed NCT NCT00298285

    ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement

    Not yet reported The Cleveland Clinic 100 participants Est. completion 2006-10 1 site
    Other conditions: Mechanical Valve Replacement, Warfarin Therapy
    View official trial listing →
  • Completed NCT NCT00321009

    LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin

    Not yet reported Corewell Health East 60 participants Est. completion 2004-04 6 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00329238

    Secondary Prevention of Venous Thrombo Embolism (VTE).

    Not yet reported Boehringer Ingelheim 2867 participants 275 sites Stand-alone
    Other conditions: Thromboembolism
    View official trial listing →
  • Completed NCT NCT00334464

    A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"

    Not yet reported Intermountain Health Care, Inc. 200 participants Est. completion 2007-11 1 site
    Other conditions: Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT00345618

    Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach

    Not yet reported Sanofi 3202 participants Est. completion 2010-10 38 sites Stand-alone
    Other conditions: Embolism, Thrombosis
    View official trial listing →
  • Completed NCT NCT00356759

    Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients

    Not yet reported Hamilton Health Sciences Corporation 250 participants Est. completion 2010-02 1 site
    Other conditions: Atrial Fibrillation, Heart Valve Diseases, Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT00365950

    3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE

    Not yet reported British Thoracic Society 2400 participants Est. completion 2003-12 2 sites
    Other conditions: Deep Vein Thrombosis, Pulmonary Embolism, Deep Vein Thrombosis With Pulmonary Embolism
    View official trial listing →
  • Withdrawn NCT NCT00377143

    PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care

    Not yet reported University of Florida 1 site
    Other conditions: Blood Coagulation Disorders
    View official trial listing →
  • Completed NCT NCT00401414

    Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information

    Not yet reported Brigham and Women's Hospital 344 participants Est. completion 2011-06 2 sites Stand-alone
    Other conditions: Pulmonary Embolism, Deep Vein Thrombosis, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00401583

    A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes

    Not yet reported GlaxoSmithKline 24 participants Est. completion 2008-02-20 2 sites Stand-alone
    Other conditions: Carcinoma, Renal Cell
    View official trial listing →
  • Completed NCT NCT00404274

    A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers

    Not yet reported GlaxoSmithKline 97 participants Est. completion 2007-03-18 2 sites Stand-alone
    Other conditions: Nausea and Vomiting, Chemotherapy-Induced
    View official trial listing →
  • Completed NCT NCT00412984

    Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation

    Not yet reported Bristol-Myers Squibb 20976 participants Est. completion 2011-05-25 1111 sites
    Other conditions: Atrial Fibrillation, Atrial Flutter
    View official trial listing →
  • Status unknown NCT NCT00432796

    PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 1473 participants Est. completion 2020-12 8 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00448396

    Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

    Not yet reported Novartis Pharmaceuticals 17 participants 1 site
    Other conditions: Advanced Malignancies
    View official trial listing →
  • Terminated NCT NCT00450008

    Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer

    Not yet reported The Methodist Hospital Research Institute 9 participants Est. completion 2008-09 1 site
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT00465218

    Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement

    Ottawa Heart Institute Research Corporation 70 participants Est. completion 2011-03 1 site
    Other conditions: Aortic Valve Disease
    View official trial listing →
  • Terminated NCT NCT00468260

    The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

    Not yet reported Novartis Pharmaceuticals 12 participants 1 site
    Other conditions: Advanced Malignancies
    View official trial listing →
  • Completed NCT NCT00479362

    Anticoagulant Therapy During Pacemaker Implantation

    Not yet reported University of Turku 447 participants Est. completion 2012-09 1 site Stand-alone
    Other conditions: Hemorrhage, Thrombosis, Embolism
    View official trial listing →
  • Status unknown NCT NCT00484640

    Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing

    Not yet reported Agency for Healthcare Research and Quality (AHRQ) 260 participants Est. completion 2008-05 2 sites
    Other conditions: Atrial Fibrillation, Deep Venous Thrombosis, Heart Valve Replacement, Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT00487136

    Interaction Between ABT-335, Rosuvastatin and Warfarin

    Not yet reported AstraZeneca 45 participants Est. completion 2007-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00515541

    Lovaza's Effect on the Activation of Platelets

    Not yet reported Invitrox 43 participants Est. completion 2009-06
    Cardiovascular disease Other conditions: Bleeding
    View official trial listing →
  • Terminated NCT NCT00522392

    Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone

    Not yet reported National Cancer Institute (NCI) 48 participants Est. completion 2014-07 276 sites
    Other conditions: Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT00524862

    Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death

    Not yet reported Unity Health Toronto 5000 participants Est. completion 2011-04 10 sites
    Heart failureSubstance use disorder Other conditions: Coronary Heart Disease, Ventricular Dysfunction, Low Cardiac Output
    View official trial listing →
  • Completed NCT NCT00533026

    Duloxetine - Warfarin Pharmacodynamic Study

    Not yet reported Eli Lilly and Company 60 participants Est. completion 2007-10 1 site
    Other conditions: Anticoagulant Effect of Warfarin When Taken With Duloxetine.
    View official trial listing →
  • Terminated NCT NCT00559988

    Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

    Not yet reported Biotronik, Inc. 2718 participants Est. completion 2013-06 80 sites Stand-alone
    Cardiovascular disease Other conditions: Atrial Fibrillation, Atrial Flutter, Embolism, Systemic Arterial, Major Bleeding
    View official trial listing →
  • Status unknown NCT NCT00564356

    The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment

    Not yet reported Sheba Medical Center 75 participants Est. completion 2010-12 1 site
    Other conditions: Efficacy, Complications
    View official trial listing →
  • Terminated NCT NCT00580216

    Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

    Not yet reported Sanofi 3773 participants Est. completion 2010-10 538 sites Stand-alone
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00595426

    A Study to Evaluate the Safety and Efficacy of YM150 in Patients With Knee Replacement Surgery

    Not yet reported Astellas Pharma Inc 685 participants Est. completion 2009-05 54 sites
    Other conditions: Arthroplasty, Replacement, Knee
    View official trial listing →
  • Completed NCT NCT00603317

    Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid

    Not yet reported Assistance Publique - Hôpitaux de Paris 13 participants Est. completion 2010-03 1 site
    Other conditions: Oral Anticoagulation, Deep Venous Thrombosis, Atrial Fibrillation, Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT00618579

    Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin

    Not yet reported ThromboGenics 15 participants Est. completion 2008-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00623987

    Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants

    Not yet reported Azienda Ospedaliera Universitaria Policlinico 500 participants Est. completion 2008-01 1 site
    Other conditions: Deep Vein Thrombosis
    View official trial listing →
  • Completed NCT NCT00643201

    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism

    Not yet reported Bristol-Myers Squibb 5614 participants Est. completion 2013-03 381 sites Stand-alone
    Other conditions: Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT00645853

    Long-term Safety in Atrial Fibrillation Patients

    Not yet reported AstraZeneca 523 participants Est. completion 2009-05
    Other conditions: Persistent or Permanent Nonvalvular Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00662467

    Warfarin After Anterior ST-Elevation Myocardial Infarction

    Not yet reported Hamilton Health Sciences Corporation 20 participants Est. completion 2008-01 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00665613

    The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin

    Northwell Health 300 participants Est. completion 2009-03 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Terminated NCT NCT00673439

    Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

    Not yet reported University of Louisville 3 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Heparin-Induced Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT00680186

    Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

    Not yet reported Boehringer Ingelheim 2589 participants 220 sites
    Other conditions: Thromboembolism
    View official trial listing →
  • Completed NCT NCT00683189

    Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy

    Not yet reported The Cooper Health System 10 participants Est. completion 2008-05 1 site
    Other conditions: Metachromatic Leukodystrophy
    View official trial listing →
  • Completed NCT NCT00684307

    Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

    Not yet reported AstraZeneca 1084 participants Est. completion 2008-06
    Other conditions: Nonvalvular Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT00691470

    Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation

    Not yet reported, Not yet reported ARYx Therapeutics 600 participants Est. completion 2009-06 41 sites
    Cardiovascular disease Other conditions: Atrial Fibrillation, Atrial Flutter, Venous Thromboembolic Disease, Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT00721136

    Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation

    Not yet reported Johns Hopkins University 104 participants Est. completion 2010-08 2 sites Stand-alone
    Other conditions: Bradycardia, Tachycardia, Atrial Fibrillation, Valvular Heart Disease
    View official trial listing →
  • Completed NCT NCT00726726

    Drug Interaction Study With a Potential Alzheimer's Disease Compound

    Not yet reported Bristol-Myers Squibb 22 participants Est. completion 2008-10 1 site Stand-alone
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT00735189

    Does Anticoagulant Control Change Following Referral Back to the Primary Care Physician?

    Not yet reported University of Alberta 96 participants Est. completion 2010-04 1 site
    Other conditions: Warfarin
    View official trial listing →
  • Completed NCT NCT00740493

    Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)

    Not yet reported University Hospital, Brest 104 participants Est. completion 2017-01 14 sites
    Other conditions: Recurrent Venous Thromboembolism, Idiopathic Deep Vein Thrombosis
    View official trial listing →
  • Completed NCT NCT00781391

    Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation

    Not yet reported Daiichi Sankyo 21105 participants Est. completion 2013-05 1009 sites Stand-alone
    Cardiovascular disease Other conditions: Atrial Fibrillation, Embolism
    View official trial listing →
  • Completed NCT NCT00787150

    A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation

    Not yet reported Pfizer 222 participants Est. completion 2009-09 18 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00788736

    Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism

    Ottawa Hospital Research Institute 2537 participants Est. completion 2016-10 12 sites
    Other conditions: Venous Thromboembolism
    View official trial listing →
  • Terminated NCT NCT00790842

    Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

    Not yet reported, Not yet reported PrECOG, LLC. 63 participants Est. completion 2018-03-08 16 sites
    Other conditions: Multiple Myeloma, Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00794755

    Low Dose Supplementation to Improve Anticoagulation Control With Oral Vitamin K as an Adjuvant to Warfarin Therapy

    Not yet reported Ottawa Hospital Research Institute 100 participants Est. completion 2010-04 1 site
    Other conditions: Coagulation
    View official trial listing →
  • Terminated NCT NCT00800137

    Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial

    Not yet reported Ottawa Heart Institute Research Corporation 984 participants Est. completion 2013-03 22 sites Stand-alone
    Other conditions: Hematoma
    View official trial listing →
  • Completed NCT NCT00806624

    DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation

    Not yet reported Daiichi Sankyo Co., Ltd. 234 participants Est. completion 2009-11 4 sites
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00830570

    The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings

    Medco Health Solutions, Inc. 1635 participants Est. completion 2010-01 1 site
    Other conditions: Embolism and Thrombosis, Embolism, Vascular Diseases, Warfarin, Venous Thromboembolism, Thrombosis, Thromboembolism
    View official trial listing →
  • Completed NCT NCT00839657

    Clarification of Optimal Anticoagulation Through Genetics

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 1015 participants Est. completion 2013-11 18 sites Stand-alone
    Cardiovascular disease Other conditions: Venous Thrombosis, Atrial Fibrillation, Atrial Flutter
    View official trial listing →
  • Completed NCT NCT00851578

    ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology

    Not yet reported Boston Scientific Corporation 150 participants Est. completion 2013-12 4 sites Stand-alone
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00868712

    Warfarin and Coronary Calcification Project

    Walter Reed Army Medical Center 70 participants Est. completion 2010-01 1 site
    Other conditions: Coronary Calcification
    View official trial listing →
  • Terminated NCT NCT00870298

    Computer Stop Order Alert to Prevent Concurrent Prescribing of Trimethoprim/Sulfamethoxazole and Warfarin

    Not yet reported University of Pennsylvania 1971 participants Est. completion 2007-01 Stand-alone
    Other conditions: Prescribers' Drug Orders
    View official trial listing →
  • Terminated NCT NCT00872079

    Personalized Warfarin Dosing by Genomics and Computational Intelligence

    Not yet reported US Department of Veterans Affairs 175 participants Est. completion 2011-09 1 site
    Cardiovascular disease Other conditions: Venous Thrombosis, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00880932

    Warfarin and Non-Steroidal Anti-Inflammatory Drugs (NSAID) Customized Alert

    Not yet reported University of Pennsylvania 1865 participants Est. completion 2007-12 1 site Stand-alone
    Other conditions: Warfarin and NSAID
    View official trial listing →
  • Status unknown NCT NCT00895505

    D-Dimer Guided Oral Anticoagulant Treatment (OAT)

    Not yet reported University Hospital, Bonn 300 participants Est. completion 2012-02 1 site
    Other conditions: Deep Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT00904176

    Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects

    Not yet reported AstraZeneca 30 participants Est. completion 2009-08 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00904293

    Genotype-Guided Warfarin Therapy Trial

    Not yet reported University of North Carolina, Chapel Hill 109 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism, Artificial Heart Valve
    View official trial listing →
  • Completed NCT NCT00904982

    Randomized Trial of Interventions to Improve Warfarin Adherence

    Not yet reported University of Pennsylvania 268 participants Est. completion 2013-12 2 sites Stand-alone
    Other conditions: Atrial Fibrillation, Deep Vein Thrombosis, Dilated Cardiomyopathies
    View official trial listing →
  • Completed NCT NCT00905177

    Predictors of Anticoagulation Control on Warfarin Therapy

    University of Pennsylvania 687 participants Est. completion 2013-08 2 sites
    Other conditions: Atrial Fibrillation, Deep Vein Thrombosis, Heart Valve Replacement
    View official trial listing →
  • Completed NCT NCT00910364

    Feasibility Study of Exercise in Patients With Leg Blood Clots

    Not yet reported University of Oklahoma 5 participants Est. completion 2016-12 1 site
    Other conditions: Deep Vein Thrombosis
    View official trial listing →
  • Completed NCT NCT00914667

    The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

    Not yet reported Pfizer 14 participants Est. completion 2009-08 1 site Stand-alone
    Other conditions: Urinary Bladder, Overactive
    View official trial listing →
  • Completed NCT NCT00927862

    Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin

    Not yet reported, Not yet reported Intermountain Health Care, Inc. 2415 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Thromboembolism
    View official trial listing →
  • Completed NCT NCT00928915

    International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage

    Not yet reported Heidelberg University 54 participants Est. completion 2015-01 1 site
    Other conditions: Intracranial Hemorrhages
    View official trial listing →
  • Completed NCT NCT00938132

    A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers

    Not yet reported Boryung Pharmaceutical Co., Ltd 15 participants Est. completion 2009-09 Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00938730

    A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation

    Not yet reported Astellas Pharma Inc 1280 participants Est. completion 2010-09 170 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00954928

    The Safety of Hand Surgery in the Anticoagulated Patient

    Washington University School of Medicine 398 participants Est. completion 2015-06 1 site
    Other conditions: Hand Surgery
    View official trial listing →
  • Terminated NCT NCT00957242

    AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis

    Not yet reported Duke University 145 participants Est. completion 2011-07 22 sites
    Other conditions: Idiopathic Pulmonary Fibrosis
    View official trial listing →
  • Completed NCT NCT00964353

    Clinical and Economic Implications of Genetic Testing for Warfarin Management

    Not yet reported University of Chicago 359 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Blood Coagulation Disorders
    View official trial listing →
  • Completed NCT NCT00966290

    Anticoagulant Clinics and Vitamin K Antagonists

    Not yet reported University Hospital, Toulouse 1006 participants Est. completion 2006-12 7 sites Stand-alone
    Other conditions: Blood Coagulation Disorders
    View official trial listing →
  • Completed NCT NCT00986154

    Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

    Not yet reported Daiichi Sankyo 8292 participants Est. completion 2013-04 454 sites
    Other conditions: Venous Thromboembolism, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Thromboembolism, Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT00990158

    Does Low Dose Oral Vitamin K Improve International Normalized Ratio (INR) Stability?

    Not yet reported St. Joseph's Healthcare Hamilton 235 participants Est. completion 2014-04 4 sites
    Other conditions: Coagulation, Bleeding, Thrombosis
    View official trial listing →
  • Completed NCT NCT01001299

    A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma

    Not yet reported Hoffmann-La Roche 25 participants Est. completion 2012-02-29 5 sites Stand-alone
    Other conditions: Malignant Melanoma
    View official trial listing →
  • Completed NCT NCT01017666

    BIIB014 Effects on the Pharmacokinetics (PK) of Rosiglitazone, Warfarin, and Midazolam

    Not yet reported Biogen 28 participants Est. completion 2010-06-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01020656

    Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery

    Centre Hospitalier Universitaire Dijon 206 participants Est. completion 2009-06 1 site
    Other conditions: Retinal Detachment
    View official trial listing →
  • Completed NCT NCT01033279

    Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy

    Not yet reported Montreal Heart Institute 120 participants Est. completion 2010-05 1 site
    Other conditions: Anticoagulants, Quality of Life, Drug Monitoring, Pharmacy, Ambulatory Care
    View official trial listing →
  • Completed NCT NCT01034124

    Mechanisms Underlying Drug-Diet Interactions

    Not yet reported University of North Carolina, Chapel Hill 19 participants Est. completion 2008-06 1 site
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Terminated NCT NCT01036802

    Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease

    Not yet reported University of North Carolina, Chapel Hill 3 participants Est. completion 2012-09 1 site
    Other conditions: Pulmonary Hypertension
    View official trial listing →
  • Status unknown NCT NCT01050920

    Study of Genetic Factors Other Than CYP2C9 and VKORC1 That Influence Warfarin Dose Requirements in a South-east Asian Population

    National University Hospital, Singapore Est. completion 2014-12 1 site
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT01081327

    Warfarin - How Good Are we at Maintaining Target Range ?

    University of Dundee 5000 participants Est. completion 2016-03-01 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01095588

    Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male Subjects

    Not yet reported VIVUS LLC 24 participants Est. completion 2010-05
    Other conditions: Erectile Dysfunction
    View official trial listing →
  • Completed NCT NCT01118299

    AMPLATZER Cardiac Plug Clinical Trial

    Not yet reported Abbott Medical Devices 97 participants Est. completion 2018-12-06 18 sites
    Cardiovascular disease Other conditions: Atrial Fibrillation, Peripheral Thromboembolism
    View official trial listing →
  • Completed NCT NCT01119300

    EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin

    Not yet reported Utrecht Institute for Pharmaceutical Sciences 455 participants Est. completion 2013-10 3 sites Stand-alone
    Other conditions: Venous Thromboembolism, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01124058

    Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial

    Not yet reported University of Alberta 39 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Anticoagulation
    View official trial listing →
  • Completed NCT NCT01147731

    A Drug Interaction Study With Albiglutide and Warfarin

    Not yet reported GlaxoSmithKline 16 participants Est. completion 2010-09-09 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01164046

    Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism

    Not yet reported University Medical Center Groningen 56 participants Est. completion 2014-07 14 sites
    Other conditions: Venous Thromboembolism, Neoplasms
    View official trial listing →
  • Completed NCT NCT01178502

    PGx Study to Develop and Validate the Predictive Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy

    Inje University 405 participants Est. completion 2010-04 1 site
    Other conditions: Heart Valve Diseases
    View official trial listing →
  • Completed NCT NCT01178853

    Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers

    Not yet reported Kowa Research Institute, Inc. 48 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01199341

    A Drug-Drug Interaction Study to Study the Effect of AZD1981 on Warfarin

    Not yet reported AstraZeneca 28 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Pharmakokinetic
    View official trial listing →
  • Withdrawn NCT NCT01214122

    A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin

    Not yet reported AstraZeneca Est. completion 2010-12 2 sites Stand-alone
    Other conditions: Pharmacokinetics, Pharmacodynamics
    View official trial listing →
  • Completed NCT NCT01227629

    PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin

    Not yet reported Boehringer Ingelheim 502 participants 38 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01250535

    Human Cytochrome P450 4F Enzymes and Drug Interactions

    Not yet reported University of North Carolina, Chapel Hill 19 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Healthy Volunteers, Drug Drug Interactions
    View official trial listing →
  • Completed NCT NCT01285661

    Optimal Duration of Anticoagulation in Deep Venous Thrombosis

    Not yet reported University of Padova 584 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Deep Vein Thrombosis of Lower Limb, Lower Extremity Deep Venous Thrombosis Recurrent
    View official trial listing →
  • Completed NCT NCT01287598

    BAY73-4506 Probe Substrate Study

    Not yet reported Bayer 41 participants Est. completion 2018-07-30 4 sites Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT01317927

    A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies

    Not yet reported Spectrum Pharmaceuticals, Inc 27 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Solid Tumor, Hematological Malignancy
    View official trial listing →
  • Completed NCT NCT01326949

    Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis

    Not yet reported Air Force Military Medical University, China 52 participants Est. completion 2016-01 1 site
    Other conditions: Decompensated Cirrhosis, Portal Vein Thrombosis, Bleeding Varices
    View official trial listing →
  • Completed NCT NCT01340846

    A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

    Not yet reported GlaxoSmithKline 48 participants Est. completion 2012-11-14 11 sites Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT01348074

    Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist

    Not yet reported McMaster University 104 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Atrial Fibrillation, Venous Thromboembolism, Heart Valve Disease, Surgery
    View official trial listing →
  • Status unknown NCT NCT01349712

    Study to Test the Accuracy of a Prototype Handheld PT/INR Device

    Universal Biosensors Pty Ltd 200 participants Est. completion 2011-11 1 site
    Other conditions: Blood Coagulation Disorders
    View official trial listing →
  • Completed NCT NCT01375725

    Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood

    Universal Biosensors Pty Ltd 60 participants Est. completion 2010-09 1 site
    Other conditions: Clotting Disorders
    View official trial listing →
  • Completed NCT NCT01388335

    A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin

    Not yet reported Eli Lilly and Company 13 participants Est. completion 2012-12 7 sites Stand-alone
    Other conditions: Solid Tumor, Lymphoma, Malignant
    View official trial listing →
  • Completed NCT NCT01391962

    Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

    Not yet reported National Cancer Institute (NCI) 34 participants Est. completion 2026-01-16 1 site Stand-alone
    Other conditions: Sarcoma, Alveolar Soft Part
    View official trial listing →
  • Completed NCT NCT01431326

    Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

    Daniel Benjamin 3520 participants Est. completion 2019-11 52 sites
    Chronic kidney diseaseHeart failure Other conditions: Adenovirus, Anesthesia, Anxiety, Anxiolysis, Autism, Autistic Disorder, Bacterial Meningitis, Bacterial Septicemia, Benzodiazepine, Bipolar Disorder, Bone and Joint Infections, Central Nervous System Infections, Convulsions, Cytomegalovirus Retinitis, Early-onset Schizophrenia Spectrum Disorders, Epilepsy, General Anesthesia, Gynecologic Infections, Herpes Simplex Virus, Infantile Hemangioma, Infection, Inflammation, Inflammatory Conditions, Intra-abdominal Infections, Lower Respiratory Tract Infections, Migraines, Pain, Pneumonia, Schizophrenia, Sedation, Seizures, Skeletal Muscle Spasms, Skin and Skin-structure Infections, Treatment-resistant Schizophrenia, Urinary Tract Infections, Withdrawal, Sepsis, Gram-negative Infection, Bradycardia, Cardiac Arrest, Cardiac Arrhythmia, Staphylococcal Infections, Nosocomial Pneumonia, Neuromuscular Blockade, Methicillin Resistant Staphylococcus Aureus, Endocarditis, Neutropenia, Headache, Fibrinolytic Bleeding, Pulmonary Arterial Hypertension, CMV Retinitis, Hypertension, Hyperaldosteronism, Hypokalemia, Hemophilia, Heavy Menstrual Bleeding, Insomnia
    View official trial listing →
  • Completed NCT NCT01431690

    Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals

    Not yet reported AstraZeneca 52 participants Est. completion 2011-10 1 site Stand-alone
    Other conditions: Hypertriglyceridemia
    View official trial listing →
  • Completed NCT NCT01438580

    The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation

    Not yet reported Nanjing Medical University 260 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01447511

    Pharmacogenetics of Warfarin Induction and Inhibition

    Not yet reported University of Minnesota 39 participants Est. completion 2013-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01452347

    Dabigatran Etexilate in Patients With Mechanical Heart Valves

    Not yet reported Boehringer Ingelheim 328 participants Est. completion 2013-06 40 sites
    Other conditions: Heart Valve Diseases
    View official trial listing →
  • Completed NCT NCT01452568

    Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirin

    Not yet reported Copenhagen University Hospital, Rigshospitalet 370 participants Est. completion 2012-03
    Other conditions: Thromboembolism, Bleeding
    View official trial listing →
  • Completed NCT NCT01474460

    Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy

    Not yet reported James A. Haley Veterans Administration Hospital 370 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Coagulation Delay
    View official trial listing →
  • Completed NCT NCT01475279

    A Study to Evaluate the Effect of T89(Dantonic®)on Steady-State Pharmacodynamics of Warfarin

    Not yet reported Tasly Pharmaceuticals, Inc. 24 participants Est. completion 2012-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01505881

    Follow on Study From RE-ALIGN

    Not yet reported Boehringer Ingelheim 158 participants Est. completion 2013-06 30 sites
    Other conditions: Thromboembolism, Heart Valve Prosthesis
    View official trial listing →
  • Completed NCT NCT01507051

    Switching Study From Warfarin to Rivaroxaban

    Not yet reported Bayer 96 participants Est. completion 2009-11 2 sites Stand-alone
    Other conditions: Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT01516814

    Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients

    Not yet reported Bayer 40 participants Est. completion 2013-11 31 sites
    Other conditions: Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT01516840

    Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

    Not yet reported Bayer 60 participants Est. completion 2014-01 29 sites
    Other conditions: Deep Vein Thrombosis
    View official trial listing →
  • Status unknown NCT NCT01518231

    Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke

    Not yet reported Zhejiang Hospital 40 participants Est. completion 2013-12 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01526083

    Effect of Lacosamide 200 mg Twice a Day (Bid) on Single Dose Warfarin 25 mg in Healthy Males

    Not yet reported UCB Pharma 16 participants Est. completion 2012-03 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Terminated NCT NCT01556659

    LV Thrombus After Acute AMI: A Randomized Controlled Trial

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 25 participants Est. completion 2022-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01561937

    Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment

    Not yet reported Novo Nordisk A/S 127 participants Est. completion 2008-07 1 site Stand-alone
    Other conditions: Haemostasis, Healthy
    View official trial listing →
  • Completed NCT NCT01597310

    Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study

    Not yet reported Knopp Biosciences 15 participants Est. completion 2012-07 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Withdrawn NCT NCT01607359

    Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation

    Corewell Health East Est. completion 2017-04-20 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT01633957

    A Trial of Genotype-based Warfarin Initiation in Patients With Mechanical Prosthetic Heart Valve

    Not yet reported Xi Zhang 200 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: Anticoagulation Treatment Overdose, Heart Valve Diseases
    View official trial listing →
  • Completed NCT NCT01636557

    A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis

    Not yet reported Janssen Research & Development, LLC 12 participants Est. completion 2013-10-19 5 sites Stand-alone
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT01653405

    Improving Anticoagulation Control in VISN 1

    Not yet reported VA Office of Research and Development 1260576 participants Est. completion 2016-09-30 1 site Stand-alone
    Other conditions: Anticoagulants, Atrial Fibrillation, Venous Thromboembolism
    View official trial listing →
  • Completed NCT NCT01662908

    A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

    Not yet reported Daiichi Sankyo 85 participants Est. completion 2014-03 34 sites
    Other conditions: Deep Vein Thrombosis, Venous Thrombosis
    View official trial listing →
  • Withdrawn NCT NCT01668901

    Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease

    Not yet reported Seoul National University Hospital Est. completion 2016-06 1 site Stand-alone
    Chronic kidney disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01727427

    Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

    G. d'Annunzio University 695 participants Est. completion 2017-12 46 sites
    Other conditions: Unsuspected Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT01727453

    Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.

    Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 40 participants Est. completion 2015-09 1 site
    Other conditions: Acute Gastrointestinal Bleeding
    View official trial listing →
  • Completed NCT NCT01747746

    Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study

    Not yet reported Cook County Health 33 participants Est. completion 2014-10 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation, Thrombo-embolism, Bleeding
    View official trial listing →
  • Completed NCT NCT01762891

    CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen

    Not yet reported Hospital Universitario Pedro Ernesto 22 participants Est. completion 2009-09
    Other conditions: Antiphospholipid Antibody Syndrome
    View official trial listing →
  • Completed NCT NCT01769768

    Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients

    Not yet reported Novartis Pharmaceuticals 114 participants Est. completion 2016-08 13 sites Stand-alone
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Completed NCT NCT01780987

    AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

    Not yet reported Pfizer 80 participants Est. completion 2014-09 20 sites
    Other conditions: Deep Vein Thrombosis, Pulmonary Embolism
    View official trial listing →
  • Withdrawn NCT NCT01810237

    Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy

    Not yet reported Nova Scotia Health Authority Est. completion 2013-09
    Other conditions: Venous Thromboses
    View official trial listing →
  • Completed NCT NCT01847560

    Anticoagulant Utilization Pattern

    Boehringer Ingelheim 333664 participants Est. completion 2017-11-01 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01857050

    Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins

    Meir Medical Center 236 participants Est. completion 2014-01
    Other conditions: Venous Thrombosis, Pulmonary Embolism, Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT01868243

    Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively

    Not yet reported, Not yet reported Hospital Ana Nery 27 participants Est. completion 2014-10 1 site
    Other conditions: Primary Disease
    View official trial listing →
  • Completed NCT NCT01911728

    Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

    Not yet reported Astellas Pharma Europe B.V. 14 participants Est. completion 2012-02-21 2 sites Stand-alone
    Other conditions: Pharmacokinetics of MDV3100, Castration Resistant Prostate Cancer (CRPC)
    View official trial listing →
  • Completed NCT NCT01924065

    Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation

    Not yet reported Suleyman Demirel University 112 participants Est. completion 2024-10-29 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation, Cardioversion
    View official trial listing →
  • Terminated NCT NCT01953874

    Cardiovascular Improvements With MV ASV Therapy in Heart Failure

    Not yet reported ResMed 126 participants Est. completion 2015-12 15 sites Stand-alone
    Heart failure Other conditions: Sleep Disordered Breathing
    View official trial listing →
  • Completed NCT NCT01962545

    Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study

    Not yet reported Satoshi Shizuta 690 participants Est. completion 2018-05-18 1 site Stand-alone
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01964794

    Improving Anticoagulant Therapy Through Warfarin Metabolite Profiling

    University of Arkansas 60 participants Est. completion 2016-10 2 sites
    Other conditions: Stable Target INR
    View official trial listing →
  • Completed NCT NCT01994265

    Cognitive Impairment Related to Atrial Fibrillation Prevention Trial

    Not yet reported University of Sao Paulo 200 participants Est. completion 2021-03-09 2 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT01996657

    D-Dimer Determined Anticoagulation INTENSITY in Patients With Mechanical Valve Replacement

    Wuhan Asia Heart Hospital 772 participants Est. completion 2016-06 2 sites
    Other conditions: Heart Valve Disease
    View official trial listing →
  • Completed NCT NCT02002611

    Drug-drug Interaction Study(Lobeglitazone, Warfarin)

    Not yet reported Chong Kun Dang Pharmaceutical 24 participants Est. completion 2014-05 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02017197

    Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil

    Not yet reported Federal University of São Paulo 100 participants Est. completion 2016-08 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT02022527

    Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis

    Not yet reported Pharmacoeconomic Unit, Egypt 300 participants 1 site Stand-alone
    Other conditions: Complications Due to Heart Valve Prosthesis
    View official trial listing →
  • Completed NCT NCT02024230

    Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)

    Not yet reported Fujita Health University 500 participants Est. completion 2022-12 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation, Fetal Blood Loss, Major Bleeding, All Cause Mortality
    View official trial listing →
  • Status unknown NCT NCT02029014

    Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin

    Not yet reported Lifetech Scientific (Shenzhen) Co., Ltd. 154 participants Est. completion 2016-07 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02042534

    Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation

    Not yet reported Asan Medical Center 195 participants Est. completion 2015-12 1 site
    Cardiovascular disease Other conditions: Transient Ischemic Attack
    View official trial listing →
  • Withdrawn NCT NCT02054936

    Evaluation of Wound Drainage After Knee or Hip Arthroplasty

    Not yet reported University of Michigan Est. completion 2016-02 1 site
    Other conditions: Complications; Arthroplasty
    View official trial listing →
  • Completed NCT NCT02061748

    The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage

    Boehringer Ingelheim 38499 participants Est. completion 2016-03-15 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02065388

    Pharmacogenetic Dosing of Warfarin

    Not yet reported Academia Sinica, Taiwan 300 participants Est. completion 2013-12 3 sites Stand-alone
    Cardiovascular disease Other conditions: Venous Thrombosis, Atrial Fibrillation, Atrial Flutter
    View official trial listing →
  • Completed NCT NCT02066662

    Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification

    Not yet reported RWTH Aachen University 192 participants Est. completion 2020-03 3 sites
    Other conditions: Atrial Fibrillation or Pulmonary Embolism, Need of Long Term Oral Anticoagulation Therapy (OAT), Existent Coronary or Valvular Calcification, or Both and Agatston Score > 50 in at Least One Location
    View official trial listing →
  • Status unknown NCT NCT02069132

    Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity

    University of Campania Luigi Vanvitelli 376 participants Est. completion 2018-06 3 sites
    Other conditions: Atrial Fibrillation, Thrombus Due to Heart Valve Prosthesis
    View official trial listing →
  • Completed NCT NCT02070510

    A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects

    Not yet reported Novo Nordisk A/S 52 participants Est. completion 2014-08-20 1 site Added to GLP-1
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT02079584

    Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant

    Indiana University 83 participants Est. completion 2014-08-14 1 site
    Other conditions: Venous Thromboembolism
    View official trial listing →
  • Completed NCT NCT02081807

    Sequential Expansion of Comparative Effectiveness of Anticoagulants

    Boehringer Ingelheim 221228 participants Est. completion 2017-11-01 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT02094157

    Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator Implantation

    Not yet reported McMaster University 173 participants Est. completion 2014-03 2 sites Stand-alone
    Other conditions: Cardiac Arrhythmias, Hemorrhage, Thromboembolism
    View official trial listing →
  • Status unknown NCT NCT02120170

    Prophylactic Clip Application for Colon Polypectomy in Patients With Anticoagulation

    Not yet reported Soonchunhyang University Hospital 356 participants Est. completion 2017-04 1 site
    Other conditions: Colon Polyp
    View official trial listing →
  • Withdrawn NCT NCT02120560

    Anticoagulation in AF Ablation and Effects on Neurocognitive Function

    Not yet reported University of California, San Francisco Est. completion 2015-07 1 site
    Other conditions: Atrial Fibrillation, Cerebrothromboembolus, Neurocognitive Function
    View official trial listing →
  • Terminated NCT NCT02157272

    Rivaroxaban in Thrombotic Antiphospholipid Syndrome

    Not yet reported University of Padova 121 participants Est. completion 2018-01-25 1 site
    Other conditions: Antiphospholipid Syndrome
    View official trial listing →
  • Completed NCT NCT02161731

    Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants

    Not yet reported Eli Lilly and Company 24 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02181361

    Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation

    Xijing Hospital 239 participants Est. completion 2018-10 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02182336

    Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy Volunteers

    Not yet reported Boehringer Ingelheim 23 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02183389

    Bioavailability of Warfarin After Coadministration With Multiple Doses of BI 1356 Compared to the Bioavailability of Warfarin Alone in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 18 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02191449

    The Influence of Preoperative Warfarin Medication on Thromboelastography and Blood Transfusion

    Konkuk University Medical Center 107 participants Est. completion 2015-02 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02206815

    Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"

    Not yet reported Genshan Ma 296 participants Est. completion 2019-02-20 3 sites
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02211326

    Genotype-guided Warfarin Individualized Treatment

    Not yet reported The Third Xiangya Hospital of Central South University 660 participants Est. completion 2017-05-01 15 sites Stand-alone
    Other conditions: Atrial Fibrillation, Deep Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT02238470

    Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance

    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1000 participants Est. completion 2017-09 30 sites
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02238535

    Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension

    Not yet reported Meshalkin Research Institute of Pathology of Circulation 60 participants Est. completion 2016-10 1 site
    Other conditions: Residual Pulmonary Hypertension
    View official trial listing →
  • Status unknown NCT NCT02240927

    Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves

    Not yet reported Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital 40 participants Est. completion 2015-12 1 site
    Other conditions: Pregnancy, Heart; Complications, Valve, Prosthesis
    View official trial listing →
  • Completed NCT NCT02243553

    Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers

    Not yet reported Boehringer Ingelheim 34 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02247128

    Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation

    Not yet reported St. Antonius Hospital 1016 participants Est. completion 2020-04 17 sites
    Cardiovascular disease Other conditions: Aortic Valve Disease, Bleeding
    View official trial listing →
  • Completed NCT NCT02247414

    Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection

    Not yet reported Yangzhou University 124 participants Est. completion 2018-04 1 site Stand-alone
    Other conditions: Cirrhosis, Hypertension, Status;Splenectomy, Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT02252731

    A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy Subjects

    Not yet reported Astellas Pharma Europe B.V. 22 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Pharmacokinetics of FG-4592, Healthy Subjects
    View official trial listing →
  • Terminated NCT NCT02267408

    Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin

    Not yet reported, Not yet reported McMaster University 42 participants Est. completion 2017-02-03 1 site Stand-alone
    Other conditions: Hypoprothrombinemia
    View official trial listing →
  • Status unknown NCT NCT02268630

    Long Term Outcomes of Venous Thromboembolism

    Ostfold Hospital Trust 460 participants Est. completion 2023-10 3 sites
    Other conditions: Post Thrombotic Syndrome, Chronic Thromboembolic Pulmonary Hypertension, Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT02273609

    INR Control and Atrial Fibrillation in Primary Care in Spain (PAULA)

    Vivencio Barrios 1524 participants Est. completion 2014-10
    Other conditions: Atrial Fibrillation and Flutter
    View official trial listing →
  • Completed NCT NCT02283294

    Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation

    Not yet reported University of South Florida 91 participants Est. completion 2019-06 5 sites
    Cardiovascular disease Other conditions: Transient Ischemic Attack, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02295475

    Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome

    Not yet reported Scott C. Woller, MD 48 participants Est. completion 2022-03 2 sites
    Other conditions: Antiphospholipid Syndrome, Thrombosis
    View official trial listing →
  • Completed NCT NCT02297126

    A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program

    Not yet reported Indiana University 4465 participants Est. completion 2019-05-03 1 site
    Other conditions: Adverse Drug Reaction
    View official trial listing →
  • Status unknown NCT NCT02303171

    Use of Warfarin After the First Trimester in Pregnant Women With APS

    Not yet reported Mohamed Sayed Abdelhafez 100 participants Est. completion 2025-06 2 sites
    Other conditions: Recurrent Miscarriage, Antiphospholipid Syndrome
    View official trial listing →
  • Completed NCT NCT02305030

    Effect of Opicapone at Steady State on Warfarin Pharmacokinetics

    Not yet reported Bial - Portela C S.A. 20 participants Est. completion 2014-05 Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02324686

    Vitamin K Supplementation in Patients on Hemodialysis

    Not yet reported University Health Network, Toronto 3 participants Est. completion 2017-12-18 1 site
    Other conditions: End Stage Renal Failure on Dialysis, Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT02331095

    Statin Use in Patients With Acute VTE

    Not yet reported Ohio State University 21 participants Est. completion 2020-05-20 1 site Stand-alone
    Other conditions: Venous Thromboembolism
    View official trial listing →
  • Completed NCT NCT02340988

    Drug-Drug Interaction Potential of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects

    Not yet reported Melinta Therapeutics, Inc. 36 participants Est. completion 2015-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02344901

    ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES)

    Muğla Sıtkı Koçman University 6273 participants Est. completion 2015-05 62 sites
    Cardiovascular disease Other conditions: Atrial Fibrillation and Flutter
    View official trial listing →
  • Withdrawn NCT NCT02345304

    Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin

    Not yet reported Boehringer Ingelheim Est. completion 2015-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02345356

    A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics

    University of Puerto Rico 200 participants Est. completion 2022-05-17 3 sites
    Other conditions: Atrial Fibrillation, Deep Vein Thrombosis, Cardiac Valvular Insufficiency, Coagulopathies, Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT02348723

    Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

    Not yet reported Boehringer Ingelheim 678 participants Est. completion 2016-11-14 87 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT02355730

    Blood Donation From Warfarin Users for the Development of POC INR Monitor

    Not yet reported Microvisk Technologies Ltd 1560 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Atrial Fibrillation, Pulmonary Embolism, Deep Vein Thrombosis
    View official trial listing →
  • Status unknown NCT NCT02356432

    Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW)

    Tokai University 86 participants Est. completion 2017-09 3 sites
    Cardiovascular disease Other conditions: Atrial Fibrillation Symptomatic
    View official trial listing →
  • Completed NCT NCT02371772

    Self-management of Anticoagulation Treatment

    Not yet reported Una Ørvim Sølvik 23 participants Est. completion 2009-09
    Other conditions: Long-term Oral Anticoagulant Therapy
    View official trial listing →
  • Completed NCT NCT02397382

    Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis

    Not yet reported Janssen Research & Development, LLC 16 participants Est. completion 2016-08-31 8 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Status unknown NCT NCT02398357

    The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis

    Not yet reported Shanghai Zhongshan Hospital 96 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Portal Vein Thrombosis, Liver Cirrhosis
    View official trial listing →
  • Completed NCT NCT02422589

    A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors

    Not yet reported Novartis Pharmaceuticals 33 participants Est. completion 2017-12-12 11 sites Stand-alone
    Other conditions: ALK-positive Advanced Tumors
    View official trial listing →
  • Status unknown NCT NCT02426060

    A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy Volunteers

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 12 participants Est. completion 2015-04 1 site Stand-alone
    Osteoarthritis
    View official trial listing →
  • Withdrawn NCT NCT02429453

    FFP Versus PCC in Intracranial Hemorrhage

    Not yet reported University of Utah Est. completion 2016-03 1 site
    Other conditions: Intracranial Hemorrhage, Traumatic, Intracranial Hemorrhage, Spontaneous
    View official trial listing →
  • Completed NCT NCT02434861

    An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects

    Not yet reported Tesaro, Inc. 102 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Chemotherapy-induced Nausea and Vomiting
    View official trial listing →
  • Withdrawn NCT NCT02450682

    Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study

    Not yet reported Mayo Clinic Est. completion 2017-03 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02461498

    The AHEAD Study: Monitoring Anticoagulated Patients Who Suffer Head Injury

    University of Sheffield 3556 participants Est. completion 2013-03
    Other conditions: Craniocerebral Trauma, Head Injuries, Closed
    View official trial listing →
  • Completed NCT NCT02461602

    Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients

    Duke University 251 participants Est. completion 2018-05-31 21 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02461914

    Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects

    Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 16 participants Est. completion 2016-07-13 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02468102

    Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

    Bayer 99999 participants Est. completion 2020-09-30 1 site
    Other conditions: Acute Coronary Syndrome, Venous Thrombosis, Pulmonary Embolism, Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT02475863

    Model-based Versus Traditional Warfarin Dosing in Children

    Not yet reported De Montfort University 45 participants Est. completion 2018-01 Stand-alone
    Other conditions: Congenital Heart Defects
    View official trial listing →
  • Completed NCT NCT02478177

    Addressing Real-world Anticoagulant Management Issues in Stroke

    Duke University 6000 participants Est. completion 2019-12 1 site
    Cardiovascular disease Other conditions: Intracerebral Hemorrhage
    View official trial listing →
  • Status unknown NCT NCT02485184

    TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis

    Not yet reported Air Force Military Medical University, China 120 participants Est. completion 2024-12-31 8 sites
    Other conditions: Portal Vein Thrombosis, Liver Cirrhosis
    View official trial listing →
  • Status unknown NCT NCT02502110

    Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation

    Not yet reported The Third Xiangya Hospital of Central South University 346 participants Est. completion 2019-06
    Other conditions: Paroxysmal Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT02506985

    XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis

    Not yet reported Susan Smyth 10 participants Est. completion 2016-06-29 Stand-alone
    Other conditions: Pulmonary Embolism, Venous Thrombosis
    View official trial listing →
  • Terminated NCT NCT02511041

    Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 2 participants Est. completion 2017-01-24 1 site Stand-alone
    Other conditions: PGM3
    View official trial listing →
  • Status unknown NCT NCT02522221

    Tecarfarin Anti-Coagulation Trial (TACT)

    Not yet reported Espero Biopharma 1000 participants Est. completion 2019-07-01
    Other conditions: Thromboembolism, Thrombosis
    View official trial listing →
  • Withdrawn NCT NCT02526303

    Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis

    Not yet reported Air Force Military Medical University, China Stand-alone
    Other conditions: Liver Cirrhosis, Portal Vein Thrombosis, Anticoagulation
    View official trial listing →
  • Completed NCT NCT02540668

    A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Participants

    Not yet reported AstraZeneca 15 participants Est. completion 2016-01-31 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02544932

    Pleotropic Effect of New Oral Anticoagulants

    Not yet reported Kyunghee University Medical Center 55 participants Est. completion 2017-09 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT02561897

    EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation

    Not yet reported Electrophysiology Research Foundation 5 participants Est. completion 2017-12 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02565836

    Fixed-dose Activated Versus Variable-dose Inactivated Prothrombin Complex Concentrate for Warfarin-associated Major Bleed

    Rush University Medical Center 342 participants Est. completion 2016-09-30
    Other conditions: Hemorrhage
    View official trial listing →
  • Status unknown NCT NCT02592980

    Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients

    Not yet reported University of Sao Paulo General Hospital 300 participants Est. completion 2020-12 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02599259

    Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy.

    Not yet reported AiCure 28 participants Est. completion 2016-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02608099

    Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation

    Not yet reported Baim Institute for Clinical Research 300 participants Est. completion 2017-04 19 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02610933

    Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients

    Not yet reported Onze Lieve Vrouw Hospital 117 participants Est. completion 2019-01-23 1 site
    Other conditions: Vascular Calcification
    View official trial listing →
  • Completed NCT NCT02611635

    Atrial Fibrillation Patient Preference Study

    Bayer 382 participants Est. completion 2017-02-16 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02617810

    A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy Participants

    Not yet reported Janssen Research & Development, LLC 18 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02635230

    What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.

    R&D Cardiologie 2200 participants Est. completion 2022-01 9 sites
    Cardiovascular disease Other conditions: Atrial Fibrillations, Heart Valve Prostheses, Acute Coronary Syndromes, Bleeding
    View official trial listing →
  • Completed NCT NCT02641899

    Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs

    Not yet reported Intarcia Therapeutics 33 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02646267

    The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 210 participants Est. completion 2018-08 1 site Stand-alone
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Active, not recruiting NCT NCT02677974

    On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study

    On-X Life Technologies, Inc. 510 participants Est. completion 2027-08 23 sites
    Other conditions: Thrombotic and Bleeding Events
    View official trial listing →
  • Completed NCT NCT02688088

    A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body

    Not yet reported Eli Lilly and Company 48 participants Est. completion 2021-01-06 5 sites Stand-alone
    Other conditions: Neoplasm Metastasis
    View official trial listing →
  • Terminated NCT NCT02696226

    Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.

    Not yet reported The Cleveland Clinic 3 participants Est. completion 2017-07-28 1 site Stand-alone
    Other conditions: Aortic Valve Disorder
    View official trial listing →
  • Completed NCT NCT02705976

    Prospective Trial of a Validated Algorithm for Warfarin Dosing

    Not yet reported Aalborg University Hospital 211 participants Est. completion 2015-05 Stand-alone
    Other conditions: Anticoagulation
    View official trial listing →
  • Completed NCT NCT02719431

    Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers

    Not yet reported Kowa Research Institute, Inc. 20 participants Est. completion 2016-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02734875

    Improving Quality of Care - Managing Atrial Fibrillation Through Care Teams and Health Information Technology

    Not yet reported Brigham and Women's Hospital 432 participants Est. completion 2017-08
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT02743052

    Anticoagulation in Cancer Related Stroke

    Samsung Medical Center 400 participants Est. completion 2018-12 1 site
    Cardiovascular disease Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT02744092

    Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer

    Not yet reported Alliance Foundation Trials, LLC. 811 participants Est. completion 2021-02-22 151 sites
    Other conditions: Cancer, Venous Thromboembolism, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Blood Clot
    View official trial listing →
  • Status unknown NCT NCT02753023

    Registry Of Acute meDical Emergencies in Brazil

    University of Sao Paulo General Hospital 1650 participants Est. completion 2020-05 6 sites
    Heart failure Other conditions: Acute Coronary Syndromes, Pulmonary Edema, Aortic Aneurysm, Familial Thoracic 1, Chest Pain, Pulmonary Embolism, Syncope
    View official trial listing →
  • Completed NCT NCT02754154

    Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants

    Bristol-Myers Squibb 321182 participants Est. completion 2018-12-26
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02757482

    Patient Training About the Safety of Warfarin Therapy

    Not yet reported Manisa Celal Bayar University 63 participants Est. completion 2015-06 1 site
    Other conditions: Warfarin Knowledge Level, International Normalized Ratio Control, Patient Training
    View official trial listing →
  • Status unknown NCT NCT02761941

    Excessive Warfarin Anticoagulation - Causes and Consequences

    University of Turku 25000 participants Est. completion 2019-12 1 site
    Other conditions: Anticoagulation
    View official trial listing →
  • Completed NCT NCT02764112

    Assessing the Ability of Warfarin Treated Patients to Predict Their INR

    Northeast Iowa Medical Education Foundation 87 participants Est. completion 2016-07 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Withdrawn NCT NCT02767232

    Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial

    Not yet reported University of Colorado, Denver Est. completion 2023-06
    Other conditions: Deep Vein Thrombosis, Post-Thrombotic Syndrome, Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT02769078

    Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S

    Bristol-Myers Squibb 14201 participants Est. completion 2016-02
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02772601

    This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis

    Not yet reported AbbVie 21 participants Est. completion 2017-09-22 1 site Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02777047

    Coordination of Oral Anticoagulant Care at Hospital Discharge

    Not yet reported St. Joseph's Healthcare Hamilton 56 participants Est. completion 2022-06-27 1 site
    Other conditions: Anticoagulants
    View official trial listing →
  • Completed NCT NCT02779348

    Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin

    Not yet reported Bial - Portela C S.A. 16 participants Est. completion 2006-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02780622

    A Pharmacokinetics, Pharmacodynamics and Safety Study of Warfarin in Combination With Tamiflu (Oseltamivir)

    Not yet reported Hoffmann-La Roche 20 participants Est. completion 2008-07 1 site Stand-alone
    Other conditions: Drug Therapy, Combination
    View official trial listing →
  • Status unknown NCT NCT02782338

    The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin

    Wolfson Medical Center 100 participants Est. completion 2017-12
    Other conditions: Blood Coagulation Disorders
    View official trial listing →
  • Completed NCT NCT02783040

    Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin

    Not yet reported Boehringer Ingelheim 13 participants Est. completion 2015-10-30 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02786095

    Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation (AF) (Code-AF Trial)

    Yonsei University 20000 participants Est. completion 2024-10 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT02791555

    Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers

    UConn Health 2 participants Est. completion 2017-03 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02792335

    Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

    Bristol-Myers Squibb 28000 participants Est. completion 2014-08
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02800941

    Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension

    Centre Hospitalier Universitaire de Saint Etienne 203 participants Est. completion 2023-09-05 4 sites
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT02810509

    Quality of Anticoagulation With Warfarin in Patient With Atrial Fibrillation for Secondary Stroke Prevention in Korea

    Inje University 1814 participants Est. completion 2016-10 18 sites
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02810704

    Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement

    Not yet reported Dartmouth-Hitchcock Medical Center 18883 participants Est. completion 2025-09 32 sites Stand-alone
    Other conditions: Pulmonary Embolism, Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT02833987

    Direct Oral Anticoagulants and Venous Thromboembolism

    Canadian Network for Observational Drug Effect Studies, CNODES 59525 participants Est. completion 2015-03 1 site
    Other conditions: Venous Thromboembolism, Major Bleed
    View official trial listing →
  • Status unknown NCT NCT02853526

    TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV

    Not yet reported Zaibo Jiang 100 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Portal Vein, Cavernous Transformation of, Portal Vein Thrombosis, Liver Cirrhosis, Bleeding Esophageal Varices
    View official trial listing →
  • Completed NCT NCT02864537

    Self-management of Anticoagulation Treatment

    Not yet reported University of Bergen 130 participants Est. completion 2013-03 Stand-alone
    Other conditions: Atrial Fibrillation, Venous Thromboembolism, Artificial Heart Valve
    View official trial listing →
  • Completed NCT NCT02871765

    The Educational Effectiveness for Atrial Fibrillation Patients Under Warfarin Treatment

    Not yet reported Chang Gung Memorial Hospital 122 participants Est. completion 2010-12 Stand-alone
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT02872649

    Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)

    Not yet reported Daniel Zimpfer, MD 16 participants Est. completion 2016-02 1 site
    Other conditions: Thrombosis, Bleeding
    View official trial listing →
  • Completed NCT NCT02913326

    A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)

    Not yet reported Boehringer Ingelheim 120 participants Est. completion 2018-06-22 36 sites
    Other conditions: Thromboembolism
    View official trial listing →
  • Completed NCT NCT02942407

    Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation

    Not yet reported Christopher Granger, MD 154 participants Est. completion 2019-08-12 58 sites Stand-alone
    Other conditions: Atrial Fibrillation, End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT02942576

    Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation

    Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 632 participants Est. completion 2018-09-24 75 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT02954237

    AMPLATZER™ Cardiac Plug Observational Post-Approval Study

    Abbott Medical Devices 91 participants Est. completion 2021-01-29 6 sites
    Other conditions: Non-valvular Atrial Fibrillation (NVAF)
    View official trial listing →
  • Status unknown NCT NCT02972385

    Pharmacogenomics of Warfarin in Hispanics and Latinos

    University of Arizona 400 participants Est. completion 2026-09 1 site
    Other conditions: Thrombosis, Hemorrhage
    View official trial listing →
  • Completed NCT NCT02981472

    A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation

    Not yet reported Bristol-Myers Squibb 192 participants Est. completion 2021-10-18 46 sites
    Other conditions: Thrombosis
    View official trial listing →
  • Completed NCT NCT02982590

    Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus

    Not yet reported Universiti Sains Malaysia 27 participants Est. completion 2018-11 1 site
    Other conditions: Left Ventricular Thrombosis
    View official trial listing →
  • Completed NCT NCT02982850

    Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease

    Not yet reported Asan Medical Center 120 participants Est. completion 2020-10 1 site Stand-alone
    Other conditions: Atrial Fibrillation, Valve Heart Disease
    View official trial listing →
  • Completed NCT NCT03006341

    Validation of Predictors of OAC Initiation Using EMR Data

    Boehringer Ingelheim 140187 participants Est. completion 2017-05-09 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT03062319

    Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis

    Not yet reported National Hospital Organization Osaka National Hospital 321 participants Est. completion 2023-07-18 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation, Atherothrombosis
    View official trial listing →
  • Status unknown NCT NCT03078374

    MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)

    Not yet reported Institute for Clinical and Experimental Medicine 15 participants Est. completion 2022-10
    Heart failureCardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03088072

    A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure

    Not yet reported Scripps Health 75 participants Est. completion 2019-12-31 1 site
    Other conditions: Non-Valvular Atrial Fibrillation, Left Atrial Appendage Closure
    View official trial listing →
  • Completed NCT NCT03103763

    Anticoagulation Therapy in the Very Old

    Robert Stein 132 participants Est. completion 2019-09-03 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT03124030

    Intra- and Post- Operative Bleeding After Simple Dental Extraction in Direct Oral Anticoagulant Therapy

    University of Trieste 128 participants Est. completion 2018-11-15 1 site
    Other conditions: Anticoagulant-induced Bleeding, Dental Diseases
    View official trial listing →
  • Completed NCT NCT03125668

    Impact of Telephone Follow-up in Patient's Health-related Quality of Life That Use Warfarin

    Not yet reported University of Sao Paulo 52 participants Est. completion 2017-11-30 1 site Stand-alone
    Other conditions: Quality of Life, Warfarin, Health Education, Patient Compliance
    View official trial listing →
  • Status unknown NCT NCT03147638

    Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)

    Not yet reported Marshall University 70 participants Est. completion 2019-06-30 1 site Stand-alone
    Other conditions: Heparin-induced Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT03153150

    Start or STop Anticoagulants Randomised Trial (SoSTART)

    Not yet reported University of Edinburgh 203 participants Est. completion 2021-03-26 67 sites Stand-alone
    Other conditions: Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive, Subarachnoid Hemorrhage, Subdural Hematoma, Intraventricular Hemorrhage, Atrial Fibrillation, Atrial Flutter, Small Vessel Cerebrovascular Disease, Microhaemorrhage
    View official trial listing →
  • Completed NCT NCT03178864

    Study of Rivaroxaban for CeREbral Venous Thrombosis

    Not yet reported University of British Columbia 55 participants Est. completion 2022-10-05 11 sites
    Other conditions: Cerebral Venous Thrombosis
    View official trial listing →
  • Status unknown NCT NCT03180567

    Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer

    Not yet reported Tanta University 20 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Thrombosis
    View official trial listing →
  • Completed NCT NCT03181386

    Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral Anticoagulants

    Not yet reported University of Sao Paulo General Hospital 60 participants Est. completion 2022-02-01 1 site
    Other conditions: Atrial Fibrillation, Periodontal Disease, Hemorrhage
    View official trial listing →
  • Status unknown NCT NCT03191305

    Comparison of the Efficacy of Rivroxaban to Coumadin( Warfarin ) in Cerebral Venous Thrombosis

    Not yet reported Foundation University Islamabad 50 participants Est. completion 2018-09
    Other conditions: Cerebral Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT03199521

    Assessment of The Effect of Apixaban in AF

    East and North Hertfordshire NHS Trust 240 participants Est. completion 2019-01-02 1 site
    Other conditions: Atrial Fibrillation, Embolism Thrombosis
    View official trial listing →
  • Completed NCT NCT03212898

    Pharmacist Interventions in Rural Elderly Warfarin Patients

    Not yet reported Slaven Falamić 131 participants Est. completion 2017-01 Stand-alone
    Other conditions: Atrial Fibrillation, Thrombosis, Cardiac Failure, Hemorrhage
    View official trial listing →
  • Status unknown NCT NCT03217448

    The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis

    Not yet reported Capital Medical University 80 participants Est. completion 2019-01 1 site
    Other conditions: Cerebral Venous Thrombosis
    View official trial listing →
  • Status unknown NCT NCT03234114

    Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 3746 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Acute Coronary Syndrome (ACS), Non-valvular Atrial Fibrillation (NVAF)
    View official trial listing →
  • Completed NCT NCT03234699

    Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs As a Means of Predicting Drug-drug Interactions

    Not yet reported SK Life Science, Inc. 24 participants Est. completion 2017-07-31 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03245307

    A Study To Test The Effect Of Apatinib On P450 Enzymes

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 20 participants Est. completion 2018-09-30 1 site Stand-alone
    Other conditions: Cytochrome P450 Interaction
    View official trial listing →
  • Completed NCT NCT03264937

    Social-software iMproving wARfarin Therapy

    Not yet reported Wuhan Asia Heart Hospital 735 participants Est. completion 2019-03-08 1 site Stand-alone
    Other conditions: Anticoagulants Causing Adverse Effects in Therapeutic Use, Patient Compliance
    View official trial listing →
  • Status unknown NCT NCT03271450

    The DARE Warfarin CER Study

    Brigham and Women's Hospital 416000 participants Est. completion 2021-10-30 1 site
    Other conditions: Deep Venous Thrombosis, Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT03292666

    Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

    University of California, San Francisco 39603 participants Est. completion 2022-06-21 2 sites
    Other conditions: Venous Thromboembolism, Anticoagulants and Bleeding Disorders
    View official trial listing →
  • Completed NCT NCT03295799

    Patient-Centred Care for Warfarin Management: A Pilot Study to Transition Care to High Risk Patients

    Not yet reported University of Alberta 58 participants Est. completion 2022-01-31 1 site Stand-alone
    Other conditions: Quality of Life
    View official trial listing →
  • Status unknown NCT NCT03299296

    Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin

    Not yet reported Ahmed AbdelMoneim Hassan Ali 100 participants Est. completion 2018-03-30
    Other conditions: Thromboses, Deep Vein, Surgery--Complications
    View official trial listing →
  • Status unknown NCT NCT03327350

    WATCHMAN for Second Prevention of Stroke (WASPS)

    Second Affiliated Hospital, Zhejiang University, School of Medicine 400 participants Est. completion 2020-11 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT03347968

    Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382

    Not yet reported MedImmune LLC 22 participants Est. completion 2018-04-09 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03359876

    Clinical Outcomes Among Non-valvular Atrial Fibrillation Patients With Renal Dysfunction

    Bayer 16000 participants Est. completion 2019-03-29 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT03363815

    A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects

    Not yet reported Celgene 56 participants Est. completion 2018-07-29 1 site Stand-alone
    Other conditions: Heathy Volunteer
    View official trial listing →
  • Completed NCT NCT03374540

    Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients

    Bayer 78517 participants Est. completion 2019-08-30 1 site
    Other conditions: Nonvalvular Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT03395639

    Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

    Not yet reported Daiichi Sankyo 168 participants Est. completion 2021-12-03 48 sites
    Other conditions: Cardiac Disease
    View official trial listing →
  • Status unknown NCT NCT03415386

    Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 120 participants Est. completion 2022-06 Stand-alone
    Cardiovascular disease Other conditions: Left Ventricular Thrombus
    View official trial listing →
  • Completed NCT NCT03426033

    Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Warfarin

    Not yet reported Akcea Therapeutics 18 participants Est. completion 2018-02-25 1 site Stand-alone
    Cardiovascular disease Other conditions: Elevated Lipoprotein(a)
    View official trial listing →
  • Completed NCT NCT03462446

    Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

    Bayer 249 participants Est. completion 2016-05-01 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Terminated NCT NCT03465735

    Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)

    Not yet reported Mayo Clinic 15 participants Est. completion 2020-01-03 1 site
    Other conditions: Acute DVT of Lower Extremity
    View official trial listing →
  • Status unknown NCT NCT03473132

    Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC)

    Not yet reported Brigham and Women's Hospital 50 participants Est. completion 2022-03-31 1 site
    Other conditions: Anticoagulation, Anticoagulation Reversal
    View official trial listing →
  • Status unknown NCT NCT03490994

    Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)

    Not yet reported Yonsei University 150 participants Est. completion 2020-01 1 site
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT03508258

    Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)

    Bristol-Myers Squibb Est. completion 2018-09-01 1 site
    Other conditions: Non-valvular Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT03512080

    Warfarin Anticoagulation in Patients in Sub-Saharan Africa

    University of Liverpool 681 participants Est. completion 2024-07-29 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03532724

    Clinical Outcomes From Patient Self-management of Antivitamin K Treatment

    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 927 participants Est. completion 2018-09-30 1 site
    Other conditions: Self Management of Oral Anticoagulation With VKA Therapy
    View official trial listing →
  • Withdrawn NCT NCT03536208

    Biological Effect of Warfarin on Pancreatic Cancer

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2022-06 1 site Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Status unknown NCT NCT03557242

    Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement

    Not yet reported Medstar Health Research Institute 124 participants Est. completion 2023-07-30 7 sites
    Other conditions: Aortic Stenosis
    View official trial listing →
  • Completed NCT NCT03561298

    A Pharmacokinetic Study to Assess Drug-drug Interaction Between Zanubrutinib and a Cocktail of Substrates in Healthy Subjects

    Not yet reported BeiGene 18 participants Est. completion 2018-07-02 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Terminated NCT NCT03566303

    Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis

    Not yet reported, Not yet reported Hospital Geral Roberto Santos 50 participants Est. completion 2020-04-26 1 site
    Cardiovascular disease Other conditions: Prostheses and Implants, Valve Heart Disease, Anticoagulants and Bleeding Disorders
    View official trial listing →
  • Completed NCT NCT03570047

    Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation

    Pfizer 73989 participants Est. completion 2018-10-31 1 site
    Other conditions: Non-valvular Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT03572972

    Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea

    Pfizer 64684 participants Est. completion 2018-12-20 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT03573037

    Anticoagulation After RFCA

    Not yet reported Yong Seog Oh 246 participants Est. completion 2020-08 1 site Stand-alone
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT03596502

    Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs Warfarin)

    Canadian Network for Observational Drug Effect Studies, CNODES 402764 participants Est. completion 2018-12-01 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation, Systemic Embolization, Major Bleed, All-cause Mortality
    View official trial listing →
  • Status unknown NCT NCT03610217

    Pragmatic Clinical Trials in Scleroderma

    Not yet reported University of West London 400 participants Est. completion 2021-10 1 site Stand-alone
    Other conditions: Scleroderma, Systemic, Sclerosis, Systemic
    View official trial listing →
  • Withdrawn NCT NCT03673605

    Efficacy and Safety of Rivaroxiban Compare With Vitamin K Antagonist Warfarin

    Not yet reported PharmEvo Pvt Ltd Est. completion 2017-12-30 1 site
    Other conditions: Mitral Valve Stenosis, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT03682419

    Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device

    LumiraDx UK Limited 420 participants Est. completion 2018-11-23 3 sites
    Cardiovascular disease Other conditions: Deep Vein Thrombosis, Atrial Fibrillation, Pulmonary Embolism, Artificial Heart Device User, Thrombophilia, Antiphospholipid Syndrome
    View official trial listing →
  • Completed NCT NCT03684395

    Accessibility to New Drugs Versus SOC in Sweden

    Bayer 68056 participants Est. completion 2017-06-30 1 site
    Other conditions: Anticoagulation
    View official trial listing →
  • Completed NCT NCT03702582

    Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation

    Not yet reported Massachusetts General Hospital 100 participants Est. completion 2023-10-01 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation, Bleeding
    View official trial listing →
  • Status unknown NCT NCT03704220

    Anti-thrombotic Monotherapy With the HeartMate 3 LVAS

    Not yet reported Institute for Clinical and Experimental Medicine 10 participants Est. completion 2021-12 1 site
    Heart failureCardiovascular disease
    View official trial listing →
  • Terminated NCT NCT03715725

    A Nationwide Observational Study Looking at Effectiveness and Bleeding Complications of NOACs vs. VKA in Non-valvular Atrial Fibrillation Patients.

    Bayer 70000 participants Est. completion 2020-01-20 1 site
    Other conditions: Non-valvular Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT03718884

    A Study of Mirikizumab in Participants With Plaque Psoriasis

    Not yet reported Eli Lilly and Company 29 participants Est. completion 2019-10-28 3 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Status unknown NCT NCT03747081

    Efficacy Comparison of Warfarin Versus Rivaroxaban CVT

    Not yet reported, Not yet reported Isfahan University of Medical Sciences 50 participants Est. completion 2020-05-01 1 site
    Other conditions: Cerebral Venous Thrombosis
    View official trial listing →
  • Completed NCT NCT03757481

    Long-term Outcome After Heparin and Edoxaban Versus Heparin Plus Vit K Antagonists for Acute DVT and PE

    Not yet reported University Hospital, Montpellier 156 participants Est. completion 2020-03-03 11 sites
    Other conditions: Post Thrombotic Syndrome, Deep Vein Thrombosis, Chronic Thromboembolic Pulmonary Hypertension
    View official trial listing →
  • Status unknown NCT NCT03760874

    Atrial Fibrillation Research Database

    University of Campania Luigi Vanvitelli 5000 participants Est. completion 2023-01-01 1 site
    Other conditions: Anticoagulants and Bleeding Disorders, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT03765242

    Evaluation of Safety and Effectiveness on Oral Anticoagulants

    Bristol-Myers Squibb 12354 participants Est. completion 2020-12-25 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT03781258

    Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS)

    Not yet reported Institute for Clinical and Experimental Medicine 20 participants Est. completion 2021-12-31 1 site
    Heart failureCardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03789695

    RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD

    Not yet reported Irina Ermolaeva 200 participants Est. completion 2022-05 1 site
    Type 2 diabetesChronic kidney disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT03797534

    Individualized Administration of Warfarin by Polymorphisms of VKORC1 and CYP2C9 Genes

    Not yet reported Fujian Medical University 600 participants Est. completion 2023-01-01 1 site
    Other conditions: Heart Valve Prosthesis
    View official trial listing →
  • Completed NCT NCT03807921

    Anticoagulation for Aortic Bioprosthesis (ANTIPRO)

    Not yet reported Instituto Nacional de Cirugia Cardiaca, Uruguay 140 participants Est. completion 2019-12-31 2 sites Stand-alone
    Other conditions: Aortic Valve Stenosis, Aortic Valve Disease, Aortic Valve Insufficiency, Aortic Valve Regurgitation
    View official trial listing →
  • Completed NCT NCT03812848

    Clinical Pharmacist-led Inpatient Anticoagulation Stewardship Program

    Not yet reported Ain Shams University 233 participants Est. completion 2022-06-05 1 site Stand-alone
    Other conditions: Deep Vein Thrombosis, Atrial Fibrillation, Mitral Valve Disease
    View official trial listing →
  • Terminated NCT NCT03839355

    Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation

    Not yet reported Mayo Clinic 34 participants Est. completion 2020-12-15 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT03866681

    Sirolimus Combined With Low-dose Warfarin for the Treatment of Refractory PNH

    Not yet reported Peking Union Medical College Hospital 40 participants Est. completion 2022-04-01 1 site Stand-alone
    Other conditions: Paroxysmal Nocturnal Hemoglobinuria
    View official trial listing →
  • Status unknown NCT NCT03870581

    AI-based Social Software to Manage wARfarin Therapy

    Not yet reported Wuhan Asia Heart Hospital 500 participants Est. completion 2021-05-01 2 sites Stand-alone
    Other conditions: Anticoagulant-induced Bleeding, Warfarin Sodium Causing Adverse Effects in Therapeutic Use
    View official trial listing →
  • Status unknown NCT NCT03885180

    Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy

    Not yet reported Wuhan Asia Heart Hospital 500 participants Est. completion 2021-03-30 1 site Stand-alone
    Other conditions: Valve Heart Disease, Anticoagulants; Increased
    View official trial listing →
  • Completed NCT NCT03889574

    Triple Antithrombotic Therapy in Cardiac Patients Requiring Revascularization

    Methodist Health System 84 participants Est. completion 2019-06-27 1 site
    Other conditions: Cardiac Disease
    View official trial listing →
  • Completed NCT NCT03894878

    Association Between Genetic Variant Scores and Warfarin Effect

    Cipherome, Inc. 200 participants Est. completion 2022-09-30 1 site
    Other conditions: Atrial Fibrillation, Deep Vein Thrombosis, Intracardiac Thrombus, Pulmonary Embolism, Venous Thromboembolic Disease
    View official trial listing →
  • Active, not recruiting NCT NCT03910933

    Electronic KIDCLOT Interactive Thrombosis/Thrombophilia Education; A Quality Assurance Initiative

    University of Alberta 248 participants Est. completion 2026-12-31 6 sites
    Other conditions: Health Literacy, Anticoagulation
    View official trial listing →
  • Terminated NCT NCT03926156

    RIvoraxaban in Mitral Stenosis

    Not yet reported Rajaie Cardiovascular Medical and Research Center 40 participants Est. completion 2021-08-14 1 site Stand-alone
    Other conditions: Mitral Stenosis, Rheumatic Heart Disease, Atrial Fibrillation, Anticoagulant Adverse Reaction
    View official trial listing →
  • Completed NCT NCT03926780

    Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi

    Not yet reported The Young Investigator Group of Cardiovascular Research 79 participants Est. completion 2020-05-01 1 site
    Other conditions: Anticoagulants; Increased, Left Ventricular Thrombosis
    View official trial listing →
  • Status unknown NCT NCT03942913

    Prospective Real-world Registry Describing Treatment Regimens

    Assistance Publique Hopitaux De Marseille 573 participants Est. completion 2023-12-31 1 site
    Other conditions: Subject Under Anticoagulant
    View official trial listing →
  • Status unknown NCT NCT03996629

    Impact of Clinical Pharmacist Interventions in Vitamin K Antagonists Management at One Teaching Hospital in Vietnam

    Not yet reported University of Medicine and Pharmacy at Ho Chi Minh City 800 participants Est. completion 2022-12-31 1 site
    Other conditions: Anticoagulation
    View official trial listing →
  • Completed NCT NCT03999905

    Impact of Pharmacists' Training on Oral Anticoagulant Counseling

    Not yet reported University of Ibadan 37 participants Est. completion 2019-10-10 1 site
    Other conditions: Deep Vein Thrombosis, Pulmonary Embolism, Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT04047654

    Efficacy and Safety of Oral Anticoagulants Among Thai Octogenarians With Nonvalvular Atrial Fibrillation

    Mahidol University 327 participants Est. completion 2019-12-31 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT04066764

    Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 200 participants Est. completion 2024-10-01 7 sites
    Other conditions: Venous Thromboembolism
    View official trial listing →
  • Status unknown NCT NCT04073316

    AntiCoagulants and COGnition

    Not yet reported University Hospital, Angers 48 participants Est. completion 2023-02 1 site
    Other conditions: Nonvalvular Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT04099238

    Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

    Bayer 3739 participants Est. completion 2020-07-16 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT04121767

    Safety and Efficacy of Edoxaban in Thoracoscopic Ablation

    Not yet reported Samsung Medical Center 60 participants Est. completion 2020-07-10 1 site
    Other conditions: Atrial Fibrillation, Anticoagulants and Bleeding Disorders
    View official trial listing →
  • Completed NCT NCT04136379

    Comparison of Home and Standard Clinic Monitoring of INR in Patients With CHD

    University of Ulster 18 participants Est. completion 2021-10-31 1 site
    Other conditions: Congenital Heart Disease, Congenital Heart Defect, Adult Congenital Heart Disease
    View official trial listing →
  • Terminated NCT NCT04142658

    PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban

    Not yet reported Artivion Inc. 863 participants Est. completion 2022-12-12 62 sites
    Other conditions: Aortic Valve Disease, Aortic Valve Stenosis, Aortic Valve Failure
    View official trial listing →
  • Completed NCT NCT04164693

    Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula

    Not yet reported First Affiliated Hospital of Chongqing Medical University 287 participants Est. completion 2022-09-30 1 site Stand-alone
    Other conditions: Thrombosis
    View official trial listing →
  • Completed NCT NCT04195113

    Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry

    McMaster University 242 participants Est. completion 2022-12-31 3 sites
    Other conditions: Atrial Fibrillation, Venous Thromboembolism, Arterial Vascular Disease
    View official trial listing →
  • Withdrawn NCT NCT04198844

    The Effectiveness and Safety of Apixaban in NVAF Patients With History of Osteoporosis and/or Fracture: A Nation-wide Population Based Study

    Pfizer Est. completion 2020-03-31 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT04234698

    Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia

    Pfizer 2076 participants Est. completion 2021-10-31 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT04235569

    Warfarin Initiation in Mechanical Mitral Valve Replacement Patients

    Not yet reported Sarah Sabry Hashem 50 participants Est. completion 2019-09-01 1 site Stand-alone
    Other conditions: Mitral Valve Disease
    View official trial listing →
  • Completed NCT NCT04249401

    Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)

    Bayer 134897 participants Est. completion 2023-09-30 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT04250116

    Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents

    Not yet reported Yonsei University 960 participants Est. completion 2026-05-08 1 site Stand-alone
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT04397289

    Anticoagulation Therapy After Splenectomy in Cirrhosis Patient

    Not yet reported, Not yet reported First Affiliated Hospital Xi'an Jiaotong University 70 participants Est. completion 2021-03-31 1 site Stand-alone
    Other conditions: Liver Cirrhosis, Portal Hypertension, Anticoagulant-induced Bleeding, Thrombosis
    View official trial listing →
  • Completed NCT NCT04435769

    Non-Interventional Study Describing Direct Costs Related to Anti-coagulation Treatment

    Pfizer 109 participants Est. completion 2021-05-31 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT04437303

    Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

    Not yet reported St. Antonius Hospital 858 participants Est. completion 2024-05-22 22 sites
    Cardiovascular disease Other conditions: Aortic Valve Disease, Aortic Valve Stenosis, Bleeding, Vascular Complications, Thrombosis Embolism
    View official trial listing →
  • Withdrawn NCT NCT04482842

    Gene-guided Warfarin for Anticoagulation Therapy

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University Est. completion 2021-08-20 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT04505475

    Oral Surgery in Patients Taking Direct Oral Anticoagulants

    University of Novi Sad 82 participants Est. completion 2020-08-03 1 site
    Other conditions: Anticoagulants and Bleeding Disorders, Surgery, Postoperative Hemorrhage, Dentoalveolar Haemorrhage
    View official trial listing →
  • Completed NCT NCT04509193

    A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes

    Bayer 116049 participants Est. completion 2021-07-31 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT04510805

    Effectiveness of NextDose for Warfarin Dose Individualization

    Not yet reported The First Affiliated Hospital of Soochow University 240 participants Est. completion 2021-12 Stand-alone
    Other conditions: Thrombosis Embolism
    View official trial listing →
  • Completed NCT NCT04518735

    Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study)

    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1707 participants Est. completion 2020-06-30 1 site
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04562116

    A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitis

    Not yet reported Galderma R&D 17 participants Est. completion 2023-06-07 6 sites Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT04569279

    Rivaroxaban vs. Warfarin in CVT Treatment

    Not yet reported Damascus University 71 participants Est. completion 2020-03-01 1 site Stand-alone
    Other conditions: Cerebral Vein Thrombosis
    View official trial listing →
  • Completed NCT NCT04593043

    Replication of the RELY Anticoagulant Trial in Healthcare Claims Data

    Brigham and Women's Hospital 78140 participants Est. completion 2021-02-18 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT04614090

    Fast Reversal of Warfarin and Early Surgery in Patients With Trochanteric Hip Fracture A Case-control Study

    Karolinska Institutet 198 participants Est. completion 2018-06-26 1 site
    Other conditions: Trochanteric Hip Fractures, Warfarin Medication, Early Surgery
    View official trial listing →
  • Completed NCT NCT04645537

    Finnish AntiCoagulation in Atrial Fibrillation (FinACAF)

    Helsinki University Central Hospital 400000 participants Est. completion 2018-12-31
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT04645550

    Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）

    Not yet reported Northern Jiangsu People's Hospital 120 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Cirrhosis, Splenectomy; Status, Venous Thrombosis, Hypertension, Portal
    View official trial listing →
  • Completed NCT NCT04662515

    NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications

    Malmö University 216 participants Est. completion 2023-12-31 2 sites
    Other conditions: Surgery, Oral, Hemorrhage, Postoperative Complications, Oral Surgical Procedures, Anticoagulants Causing Adverse Effects in Therapeutic Use, Anticoagulant-induced Bleeding
    View official trial listing →
  • Completed NCT NCT04679948

    A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood

    Not yet reported Boehringer Ingelheim 16 participants Est. completion 2021-03-17 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04681482

    Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare

    Pfizer 107383 participants Est. completion 2020-11-03 1 site
    Other conditions: Atrial Fibrillation, Obesity, Anticoagulants
    View official trial listing →
  • Withdrawn NCT NCT04684212

    Can the Lambre Device Occlude IRRegular And Large Appendages in Patients With Non-Valvular AF

    Not yet reported Brian O'Neill MD Est. completion 2024-07-11 1 site
    Other conditions: Atrial Fibrillation, Left Atrial Appendage Thrombosis, CVA
    View official trial listing →
  • Completed NCT NCT04709094

    A Drug Interaction Study of Danicopan

    Not yet reported Alexion Pharmaceuticals, Inc. 52 participants Est. completion 2020-04-17 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04730037

    Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI)

    Not yet reported Kyushu University 74 participants Est. completion 2023-06-27 1 site
    Other conditions: CTEPH
    View official trial listing →
  • Completed NCT NCT04736719

    Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data

    Brigham and Women's Hospital 19002 participants Est. completion 2021-02-18 1 site
    Other conditions: Venous Thromboembolism
    View official trial listing →
  • Withdrawn NCT NCT04794348

    Clinical Trial Assessing Non-Inferiority of Freeze Dried Plasma to Fresh Frozen Plasma in Reversing Warfarin

    Not yet reported Teleflex Est. completion 2022-03 1 site Stand-alone
    Other conditions: Anticoagulant Reversal
    View official trial listing →
  • Completed NCT NCT04846114

    Dental Implants in Patients Under Oral Anticoagulant Therapy

    Not yet reported Jorge Ernesto Aguilar 71 participants Est. completion 2019-06 1 site
    Other conditions: Oral Anticoagulant Therapy
    View official trial listing →
  • Completed NCT NCT04865978

    Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban in Left Ventricular Assist Devices

    Not yet reported Palak Shah 30 participants Est. completion 2023-11-07 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT04878497

    Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty

    Brigham and Women's Hospital 1000000 participants Est. completion 2022-12-31 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation, Frailty, Anticoagulant-induced Bleeding
    View official trial listing →
  • Completed NCT NCT04879407

    Replication of the EINSTEIN-PE Anticoagulant Trial in Healthcare Claims Data

    Brigham and Women's Hospital 98947 participants Est. completion 2021-06-11 1 site
    Other conditions: Pulmonary Embolism
    View official trial listing →
  • Completed NCT NCT04887194

    PK Study to Assess Drug-drug Interaction and QTc Between Sitravatinib and a Cocktail of Substrates

    Not yet reported Mirati Therapeutics Inc. 40 participants Est. completion 2022-12-22 5 sites Stand-alone
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Completed NCT NCT04907825

    A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF

    Not yet reported Cedars-Sinai Medical Center 14 participants Est. completion 2026-01-31 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT04970576

    Rivaroxaban in Left Ventricular Thrombus

    Not yet reported National Institute of Cardiovascular Diseases, Pakistan 261 participants Est. completion 2024-05-31 1 site
    Other conditions: Acute Coronary Syndrome, Left Ventricular Thrombus
    View official trial listing →
  • Completed NCT NCT04972396

    Pemvidutide (ALT-801) DDI Study in Healthy Volunteers

    Not yet reported Altimmune, Inc. 40 participants Est. completion 2022-05-15 2 sites Stand-alone
    MASH
    View official trial listing →
  • Completed NCT NCT04976543

    Safety of Anticoagulant Therapy After Endoscopic Treatment

    Not yet reported Qilu Hospital of Shandong University 86 participants Est. completion 2022-06-28 1 site Stand-alone
    Other conditions: Cirrhosis, Portal Vein Thrombosis, Esophageal and Gastric Varices, Anticoagulant-induced Bleeding
    View official trial listing →
  • Completed NCT NCT04994119

    Effect of BIA 5-1058 400 mg on Warfarin Pharmacokinetics

    Not yet reported Bial - Portela C S.A. 26 participants Est. completion 2018-05-23 1 site Stand-alone
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Status unknown NCT NCT05006287

    The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery

    Not yet reported St. Paul's Hospital, Canada 100 participants Est. completion 2024-05-30 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT05022758

    A Study to Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin

    Bayer 45000 participants Est. completion 2022-10-24 1 site
    Other conditions: Non-valvular Atrial Fibrillation (NVAF)
    View official trial listing →
  • Completed NCT NCT05027061

    A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagulant in the National Cerebral and Cardiovascular Center (NCVC) in Japan

    Bristol-Myers Squibb 11776 participants Est. completion 2021-12-04 1 site
    Other conditions: Non-Valvular Atrial Fibrillation (NVAF)
    View official trial listing →
  • Completed NCT NCT05045313

    A Study to Evaluate the Drug-drug Interactions (DDIs) of DBPR108 With Warfarin Sodium, Digoxin, Probenecid in Healthy Subjects

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 28 participants Est. completion 2021-12-01 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT05051904

    A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin

    Boehringer Ingelheim 39357 participants Est. completion 2022-07-29 1 site
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT05085405

    Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial

    Not yet reported University of Michigan 80 participants Est. completion 2022-01-31 1 site
    Other conditions: Upper Gastrointestinal Bleeding
    View official trial listing →
  • Completed NCT NCT05208398

    Apixaban in Patients With Left Ventricular Thrombus

    Not yet reported Saud Al Babtain Cardiac Center 50 participants Est. completion 2021-09-30 1 site
    Other conditions: Left Ventricular Thrombus
    View official trial listing →
  • Completed NCT NCT05273775

    A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 22 participants Est. completion 2022-06-23 1 site Stand-alone
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Status unknown NCT NCT05300555

    Cost-effectiveness Analysis Between Two Anticoagulation Strategies for Atrial Fibrillation in the Postoperative Period of Coronary Artery Bypass Graft Surgery

    Not yet reported University of Sao Paulo General Hospital 50 participants Est. completion 2022-11-01 1 site Stand-alone
    Other conditions: Atrial Fibrillation New Onset
    View official trial listing →
  • Completed NCT NCT05321810

    Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibrillation

    Pfizer 193565 participants Est. completion 2022-04-15 1 site
    Other conditions: Non-valvular Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT05419583

    Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction

    Not yet reported University of Edinburgh 60 participants Est. completion 2024-06-30 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05438888

    Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Compared to Warfarin Using Administrative Claims Data

    Pfizer 77814 participants Est. completion 2022-10-19 1 site
    Other conditions: Non-valvular Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT05439694

    TXA Soaked Gelatin Sponge to Reduce Rectus Sheath Hematoma After C.S. in Patients Using Warfarin

    Not yet reported Cairo University 63 participants Est. completion 2023-02-01 1 site
    Other conditions: Rectus Sheath Hematoma, Cesarean Section
    View official trial listing →
  • Completed NCT NCT05445232

    A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants

    Not yet reported Eli Lilly and Company 32 participants Est. completion 2023-02-24 2 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT05471505

    Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

    Pfizer 120722 participants Est. completion 2022-09-27 1 site
    Other conditions: Non-valvular Atrial Fibrillation
    View official trial listing →
  • Status unknown NCT NCT05545475

    Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices

    Qilu Hospital of Shandong University 100 participants Est. completion 2024-01-18 1 site
    Other conditions: Anticoagulants and Bleeding Disorders, Tissue Adhesion, Gastric Varices Bleeding
    View official trial listing →
  • Completed NCT NCT05602675

    A Drug Interaction Study of LY3871801 in Healthy Participants

    Not yet reported Eli Lilly and Company 39 participants Est. completion 2023-03-29 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05609500

    Warfarin Dosage Adjustment Model Analysis Study

    Chinese University of Hong Kong 1200 participants Est. completion 2023-12-23 1 site
    Other conditions: Warfarin
    View official trial listing →
  • Terminated NCT NCT05622500

    Best Endovenous Treatment, Including STenting, Versus Non-endovenous Treatment in Chronic Proximal Deep Venous Disease

    Not yet reported Imperial College London 12 participants Est. completion 2025-04-08 1 site Stand-alone
    Other conditions: Chronic Venous Insufficiency, Chronic Venous Thrombosis, Iliac Vein Stenosis, Iliac Vein Obstruction, Post Thrombotic Syndrome
    View official trial listing →
  • Status unknown NCT NCT05644210

    Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE

    Qilu Hospital of Shandong University 80 participants Est. completion 2025-12-30 1 site
    Other conditions: Antiphospholipid Syndrome
    View official trial listing →
  • Status unknown NCT NCT05645913

    Association of Obesity and Cardiovascular Outcomes in Atrial Fibrillation

    Ajou University School of Medicine 56272 participants Est. completion 2024-12-31 1 site
    Other conditions: Atrial Fibrillation, Obesity, Prognosis, Anticoagulants
    View official trial listing →
  • Completed NCT NCT05705089

    Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI

    Not yet reported Rajaie Cardiovascular Medical and Research Center 50 participants Est. completion 2023-04-01 2 sites
    Cardiovascular disease Other conditions: Left Ventricular Thrombus
    View official trial listing →
  • Completed NCT NCT05715541

    Inr Tracking Coumadin Use With Phone App

    Not yet reported Muhammed Onur Hanedan 24 participants Est. completion 2022-11-30 1 site
    Other conditions: Warfarin, Mobile Applications
    View official trial listing →
  • Completed NCT NCT05741385

    A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

    Not yet reported Boehringer Ingelheim 4 participants Est. completion 2024-08-23 1 site Stand-alone
    Other conditions: Liver Cirrhosis
    View official trial listing →
  • Completed NCT NCT05815680

    A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects

    Not yet reported Innovent Biologics (Suzhou) Co. Ltd. 48 participants Est. completion 2023-10-30 1 site Stand-alone
    Other conditions: Overweight Subjects, Obese Subjects
    View official trial listing →
  • Active, not recruiting NCT NCT05824923

    A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

    Not yet reported Pulnovo Medical (Wuxi) Co., Ltd. 264 participants Est. completion 2027-02 1 site Stand-alone
    Heart failureCardiovascular disease Other conditions: Pulmonary Hypertension, Hypertension, Vascular Diseases
    View official trial listing →
  • Completed NCT NCT05891119

    Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis

    Not yet reported Amgen 21 participants Est. completion 2025-02-12 7 sites Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT05942365

    A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam

    Not yet reported Guangdong Raynovent Biotech Co., Ltd 28 participants Est. completion 2023-08-04 1 site Stand-alone
    Other conditions: Drug Drug Interaction, Warfarin, Midazolam
    View official trial listing →
  • Completed NCT NCT05990894

    Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis.

    Xuanwu Hospital, Beijing 170 participants Est. completion 2024-07-31 1 site
    Other conditions: Cerebral Venous Thrombosis
    View official trial listing →
  • Active, not recruiting NCT NCT05995600

    Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

    Not yet reported Seoul National University Hospital 200 participants Est. completion 2029-06 32 sites
    Cardiovascular disease Other conditions: Antiphospholipid Syndrome, Transient Ischemic Attack, Cerebrovascular Disease, Major Bleed
    View official trial listing →
  • Completed NCT NCT06025552

    Study of TU7710 in Warfarin Anti-coagulated Healthy Male Subjects

    Not yet reported TiumBio Co., Ltd. 40 participants Est. completion 2024-08-21 1 site
    Other conditions: Hemophilia a, Hemophilia B, Blood Coagulation Disorders
    View official trial listing →
  • Active, not recruiting NCT NCT06055920

    The PEERLESS II Study

    Not yet reported Inari Medical 1200 participants Est. completion 2026-10 72 sites
    Other conditions: Pulmonary Embolism
    View official trial listing →
  • Not yet recruiting NCT NCT06138184

    Learning Theory Patient Education for Anticoagulants

    Not yet reported University of Utah 68 participants Est. completion 2026-12
    Other conditions: Knowledge, Attitudes, Practice
    View official trial listing →
  • Status unknown NCT NCT06145269

    Recanalization Rate of Acute DVT

    Not yet reported Assiut University 100 participants Est. completion 2025-06-01
    Other conditions: Acute DVT of Lower Extremity
    View official trial listing →
  • Status unknown NCT NCT06187155

    Impact of Education Level on Clinical Outcomes in Self-INR Managed Patients

    Not yet reported Cairo University 586 participants Est. completion 2024-12-01 1 site Stand-alone
    Other conditions: Atrial Fibrillation and Flutter, Mechanical Mitral Valve Prosthesis
    View official trial listing →
  • Completed NCT NCT06269302

    Comparison of the Effect of Warfarin and Direct Oral Anticoagulants

    Samsun Education and Research Hospital 346 participants Est. completion 2022-12-31 1 site
    Other conditions: Anticoagulants and Bleeding Disorders, Gastrointestinal Hemorrhage
    View official trial listing →
  • Completed NCT NCT06335134

    A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

    Not yet reported Hangzhou Sciwind Biosciences Co., Ltd. 57 participants Est. completion 2024-06-28 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Active, not recruiting NCT NCT06449469

    The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)

    Not yet reported Copenhagen University Hospital, Rigshospitalet 352 participants Est. completion 2030-04-01 2 sites Stand-alone
    Cardiovascular disease Other conditions: Aortic Valve Stenosis, Heart Diseases, Heart Valve Diseases, Valve Disease, Aortic
    View official trial listing →
  • Not yet recruiting NCT NCT06476301

    Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valves

    Not yet reported RenJi Hospital 250 participants Est. completion 2026-12-31 Stand-alone
    Other conditions: Anticoagulation
    View official trial listing →
  • Completed NCT NCT06686628

    An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates

    Not yet reported Sanofi 23 participants Est. completion 2026-04-02 1 site Stand-alone
    Other conditions: Dermatitis Atopic
    View official trial listing →
  • Completed NCT NCT06723691

    Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects

    Not yet reported Fujian Shengdi Pharmaceutical Co., Ltd. 57 participants Est. completion 2025-06-09 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT06783868

    Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control

    Kansas City Heart Rhythm Research Foundation 100 participants Est. completion 2027-06 7 sites
    Cardiovascular disease Other conditions: Atrial Fibrillation
    View official trial listing →
  • Enrolling by invitation NCT NCT06789588

    Protocol for Improvement of Therapy With Warfarin

    Not yet reported University of Pernambuco 700 participants Est. completion 2027-07 1 site Stand-alone
    Other conditions: Atrial Fibrillation (AF)
    View official trial listing →
  • Not yet recruiting NCT NCT06884384

    DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study

    Central Hospital, Nancy, France 310 participants Est. completion 2031-09-15 13 sites
    Other conditions: Antiphospholipid Syndrome (APS), Cohort Study, Thrombotic and Bleeding Events
    View official trial listing →
  • Completed NCT NCT06906861

    Epistaxis in Patients Receiving Oral Anticoagulants and Antiplatelet: Prevalence Risk Factors at a Tertiary Care Hospital in Nepal

    Institute of medicine, Maharagjung medical campus 284 participants Est. completion 2024-11-10 1 site
    Other conditions: Epistaxis
    View official trial listing →
  • Completed NCT NCT06920056

    A Study of BGM0504 in Overweight or Obese Participants

    Not yet reported BrightGene Bio-Medical Technology Co., Ltd. 28 participants Est. completion 2025-07-25 1 site Stand-alone
    Other conditions: Overweight or Obese
    View official trial listing →
  • Completed NCT NCT06949124

    A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 20 participants Est. completion 2025-06-05 1 site
    Other conditions: Endometriosis, Uterine Fibroids, Assisted Reproduction
    View official trial listing →
  • Completed NCT NCT06975605

    Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.

    Not yet reported GRIN Therapeutics, Inc. 18 participants Est. completion 2025-07-10 1 site Stand-alone
    Other conditions: Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia, Other Neurological Disorders
    View official trial listing →
  • Not yet recruiting NCT NCT06983795

    Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study

    National University Hospital, Singapore 1000 participants Est. completion 2030-12 1 site
    Cardiovascular disease Other conditions: Patent Foramen Ovale
    View official trial listing →
  • Completed NCT NCT07068841

    Pharmacokinetic Effect of Y-3 on Repaglinide，Warfarin and Omeprazole in Healthy Participants

    Not yet reported Neurodawn Pharmaceutical Co., Ltd. 24 participants Est. completion 2025-06-29 1 site Stand-alone
    Other conditions: Pharmacokinetic Profiles, Y-3 for Injection, Drug-drug Interaction, Repaglinide Tablets, Warfarin Sodium Tablets, Omeprazole Enteric-coated Capsules, Safty
    View official trial listing →
  • Not yet recruiting NCT NCT07246005

    LVT DURATION: Pilot Study of Anticoagulation Duration for Left Ventricular Thrombus

    Not yet reported Queen Mary University of London 120 participants Est. completion 2027-12-01 1 site Stand-alone
    Other conditions: Left Ventricular Thrombus
    View official trial listing →
  • Not yet recruiting NCT NCT07330869

    Warfarin Effects on Male Fertility After Cardiac Surgery

    Città di Lecce Hospital, GVM Care & Research 90 participants Est. completion 2028-06 1 site
    Other conditions: Male Infertility, Heart Valve Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07434661

    Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR

    Not yet reported Meshalkin Research Institute of Pathology of Circulation 120 participants Est. completion 2029-01 1 site
    Other conditions: Valve Disease, Heart, Atrial Fibrillation (AF), Valve Replacement Surgery, Aortic Valve Surgery, Mitral Valve Annuloplasty, Mitral Valve Repair, Mitral Valve Surgery
    View official trial listing →
  • Enrolling by invitation NCT NCT07456085

    Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves

    Not yet reported Rawalpindi Institute of Cardiology 60 participants Est. completion 2027-04-12 1 site Stand-alone
    Other conditions: Valvular Heart Disease Patients
    View official trial listing →
  • Not yet recruiting NCT NCT07471139

    SWITCH: Apixaban vs Vitamin K in HM3

    Not yet reported Columbia University 460 participants Est. completion 2029-08
    Heart failureCardiovascular disease Other conditions: LVAD (Left Ventricular Assist Device) Thrombosis, Bleeding, Thrombosis; Artery, Heart Transplant
    View official trial listing →
  • Completed NCT NCT07523347

    Efficacy and Safety of Oral Rivaroxaban in Cerebrosinovenous Thrombosis

    Not yet reported Muhammad Aamir Latif 75 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Cerebrosinovenous Thrombosis
    View official trial listing →
  • Not yet recruiting NCT NCT07548346

    MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

    Not yet reported Middle East North Africa Stroke and Interventional Neurotherapies Organization 440 participants Est. completion 2030-01 14 sites Stand-alone
    Other conditions: Cerebral Venous Sinus Thrombosis
    View official trial listing →
  • Completed NCT NCT07571460

    Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein Thrombosis

    Not yet reported Kafrelsheikh University 21 participants Est. completion 2025-03-15 1 site Stand-alone
    Other conditions: Liver Cirrhosis, Portal Vein Thrombosis
    View official trial listing →
  • Not yet recruiting NCT NCT07603700

    STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary Embolism

    Nanjing First Hospital, Nanjing Medical University 1300 participants Est. completion 2029-12-31 1 site
    Other conditions: Pulmonary Embolism, Venous Thromboembolism
    View official trial listing →
  • Not yet recruiting NCT NCT07639892

    Antithrombotic Treatment Strategies in Cervical Artery Dissection

    Not yet reported University Department of Geriatric Medicine FELIX PLATTER 1100 participants Est. completion 2030-03 Stand-alone
    Other conditions: Cervical Artery Dissection
    View official trial listing →
  • Not yet recruiting NCT NCT07644247

    STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump

    Not yet reported China National Center for Cardiovascular Diseases 370 participants Est. completion 2029-12-31 Stand-alone
    Cardiovascular disease Other conditions: LVAD (Left Ventricular Assist Device) Thrombosis, LVAD, LVAD (Left Ventricular Assist Device), LVAD-related GI Bleed, Bleeding, Thrombosis, Hemocompatibility-related Adverse Event, Ventricular Assist Device, Aspirin, Antiplatelet Therapy, Antithrombotic Therapy
    View official trial listing →
  • Not yet recruiting NCT NCT07730840

    Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke

    Not yet reported Asan Medical Center 984 participants Est. completion 2029-09-30 15 sites Stand-alone
    Cardiovascular disease Other conditions: Transient Ischemic Attack
    View official trial listing →
  • Not yet recruiting NCT NCT07750587

    Predicting Response and Exposure Changes in Cirrhosis for Effectiveness

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 45 participants Est. completion 2028-12-01
    Other conditions: Liver Cirrhosis
    View official trial listing →
  • Not yet recruiting NCT NCT07826299

    Warfarin Quality, Adherence, Range, Determinants, and Events in Egyptian Rheumatic Heart Disease and Atrial Fibrillation

    Assiut University 90 participants Est. completion 2028-10-01 1 site
    Other conditions: AF
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Warfarin Sodium, Warfarin

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.